Advertisement

Optic Atrophy in Children

  • Michael C. Brodsky
Chapter

Abstract

Optic atrophy is a morphologic sequel to a multitude of anterior visual pathway insults that culminate in the loss of retinal ganglion cell axons [631, 771, 822]. Histopathologically, it is characterized by a variable reduction of nerve diameter with loss of axons and little or no gliosis. Ophthalmoscopically, the disc retains its normal size and shows diffuse or segmental pallor. The pallor in optic atrophy has been attributed to thinning of the neural tissue of the optic disc and resulting changes in cytoarchitecture and decreased transmission of light, rather than to loss of optic disc capillaries or astrocytic proliferation [770, 772]. The ophthalmoscopic appearance of the atrophic disc alone occasionally suggests a specific mechanism of injury [934].

References

  1. 1.
    Abe T, Abe K, Aoki M, et al. Ocular changes in patients with spinocerebellar degeneration and repeated trinucleotide expansion of spinocerebellar ataxia type I gene. Arch Ophthalmol. 1997;115:231–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Aboseif S, Gasparini M, Schmidt R, Tanagho E. Wolfram’s (DIDMOAD) syndrome and its urological manifestations. Br J Urol. 1993;72:106–11.PubMedCrossRefGoogle Scholar
  3. 3.
    Abrams LS, Repka MX. Visual outcome of craniopharyngioma in children. J Pediatr Ophthalmol Strabismus. 1997;34:223–8.PubMedGoogle Scholar
  4. 4.
    Abu-Amero KK, Bosely TM. Mitochondrial abnormalities in patients with LHON-like optic neuropathies. Invest Ophthalmol Vis Sci. 2006;47:4211–20.PubMedCrossRefGoogle Scholar
  5. 5.
    Abu-Serieh B, Ghassempour K, Duprez T, et al. Stereotactic ventriculoperitoneal shunting for refractory idiopathic intracranial hypertension. Neurosurgery. 2007;60:1039–43.PubMedCrossRefGoogle Scholar
  6. 6.
    Acaroğlu G, Kansu T, Doğulu CF. Visual recovery patterns in children with Leber’s hereditary optic neuropathy. Int Ophthalmol. 2001;24:349–55.PubMedCrossRefGoogle Scholar
  7. 7.
    Adamolekun B. Etiology of Konzo, epidemic spastic paraparesis associated with cyanogenic glycosides in cassava: role of thiamine deficiency? J Neurol Sci. 2010;296:30–3.PubMedCrossRefGoogle Scholar
  8. 8.
    Adamolekun B. Neurological disorders associated with cassava diet: a review of putative etiological mechanisms. Metab Brain Dis. 2011;26:79–85.PubMedCrossRefGoogle Scholar
  9. 9.
    Adams RD, Victor M. Principles of neurology. 4th ed. New York: McGraw-Hill; 1989. p. 804.Google Scholar
  10. 10.
    Adeoti CO. Prevalence and causes of blindness in a tropical African population. West Afr J Med. 2004;23:249–52.PubMedGoogle Scholar
  11. 11.
    Aicardi J, Castelein P. Infantile neuroaxonal dystrophy. Brain. 1979;102:727–48.PubMedCrossRefGoogle Scholar
  12. 12.
    Ajlouni K, Jarrah N, El-Khateeb M, El-Zahari M, El Shanti H, Lidral A. Wolfram syndrome: identification of a phenotypic and genotypic variant from Jordan. Am J Med Genet. 2002;115:61–5.Google Scholar
  13. 13.
    Akhlaghi H, Corben L, Georgiou-Karistianis N, et al. Superior cerebellar peduncle atrophy in Friedreich’s ataxia correlates with disease symptoms. Cerebellum. 2011;10:81–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Akiyama H, Kashima T, Li D, et al. Retinal ganglion cell analysis in Leber’s hereditary optic neuropathy. Ophthalmology. 2013;120:1943–4.PubMedCrossRefGoogle Scholar
  15. 15.
    Al-Dirbashi OY, Rashed MS, Al-Qahtani K, et al. Quantification of N-acetylaspartic acid in urine by LC-MS/MS for the diagnosis of Canavan disease. J Inherit Metab Dis. 2007;30:612.PubMedCrossRefGoogle Scholar
  16. 16.
    Al-Essa M, Bakheet S, Al-Shamsan L, et al. 18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in type IV 3-methyl-glutaconic aciduria: clinical and MRI correlations. Brain Dev. 1999;21:24–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Al-Essa M, Dhaunsi GS, Rashed M, et al. Zellweger syndrome in Saudi Arabia and its distinct features. Clin Pediatr. 1999;38:77–86.CrossRefGoogle Scholar
  18. 18.
    Alexander C, Votruba M, Pesch UE, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet. 2000;26:207–10.CrossRefGoogle Scholar
  19. 19.
    Alexander C, Votruba M, Pesch UE, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet. 2000;26:211–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Al-Kateb H, Shimony JS, Vineyard M, et al. NR2F1 haploinsufficiency is associated with optic atrophy, dysmorphism and global developmental delay. Am J Med Genet. 2013;161A:377–81.PubMedCrossRefGoogle Scholar
  21. 21.
    Allali F, Benomar A, Karim A, et al. Behçet’s disease in Moroccan children: a report of 12 cases. Scand J Rheumatol. 2004;33:362–3.PubMedCrossRefGoogle Scholar
  22. 22.
    Al-Merjan JI, Pandova MG, Al-Ghanim M, et al. Registered blindness and low vision in Kuwait. Ophthalmic Epidemiol. 2005;12:251–7.Google Scholar
  23. 23.
    Aloi C, Salina A, Pasquali L, et al. Wolfram syndrome: new mutations, different phenotype. PLoS One. 2012;7:e29150.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    al-Sheyyab M, Jarrah N, Younis E, et al. Bleeding tendency in Wolfram syndrome: a newly identified feature with phenotype genotype correlation. Eur J Pediatr. 2001;160:243–6.Google Scholar
  25. 25.
    Altarescu G, Sun M, Moore DF, et al. The neurogenetics of mucolipidosis type IV. Neurology. 2002;59:306–13.PubMedCrossRefGoogle Scholar
  26. 26.
    Al-Till M, Jarrah MS, Ajlouni KM. Ophthalmologic findings in 15 patients with Wolfram syndrome. Eur J Ophthalmol. 2002;12:84–8.PubMedGoogle Scholar
  27. 27.
    Alvord EC, Lofton S. Gliomas of optic nerve or chiasm. J Neurosurg. 1988;68:85–98.PubMedCrossRefGoogle Scholar
  28. 28.
    Amati-Bonneau P, Valentino ML, Reynier P, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus’ phenotypes. Brain. 2008;131(Pt 2):338–51.Google Scholar
  29. 29.
    Amitava AK, Alarm S, Hussain R. Neuro-ophthalmic features in pediatric tubercular meningoencephalitis. J Pediatr Ophthalmol Strabismus. 2001;38:229–34.PubMedGoogle Scholar
  30. 30.
    Anderson TH, Pindborg JJ. Et tilfaelde of total pseudoanodontia forbindelse med craniedefomitet, dvaergvaekst og ectodermal dysplasia. Odont Tids. 1947;55:484–93.Google Scholar
  31. 31.
    Andersson S, Hellström A. Abnormal optic disc and retinal vessels in children with surgically treated hydrocephalus. Br J Ophthalmol. 2009;93(4):526–30.PubMedCrossRefGoogle Scholar
  32. 32.
    Andrews BM, Griffiths PG, Johnson MA, et al. Histochemical localization of mitochondrial enzyme activity in human optic nerve and retina. Br J Ophthalmol. 1999;83:231–5.Google Scholar
  33. 33.
    Angelini L, Nardocci V, Rumi C, et al. Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life. J Neurol. 1992;239:417–25.PubMedCrossRefGoogle Scholar
  34. 34.
    Anikster Y, Kleta R, Shaag A, Gahl WA, et al. Type III 3-methyl-glutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am J Med Genet. 2001;69:1218–9.Google Scholar
  35. 35.
    Arnoldi KA. Congenital nystagmus masquerading as spasmus nutans. Am Orthop J. 1996;46:171–80.Google Scholar
  36. 36.
    Arts WF, Loonen MC, Sengers RC, et al. X-linked ataxia, weakness, deafness, and loss of vision in early childhood with a fatal course. Ann Neurol. 1993;33(5):535–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Ashworth JL, Biswas S, Wraith E, et al. The ocular features of the mucopolysaccharidoses. Eye. 2006;20:553–63.PubMedCrossRefGoogle Scholar
  38. 38.
    Assink JJ, Tijmes NT, ten Brink JB, et al. A gene for X-linked optic atrophy is closely linked to the Xp11.2 region of the X chromosome. Am J Hum Genet. 1997;61:934–9.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Atchaneeyasakul LO, Linck LM, Connor WE, et al. Eye findings in 8 children and a spontaneously aborted fetus with RSH/Smith-Lemli-Optiz syndrome. Am J Med Genet. 1998;80:501–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Atmaca LS, Simsek T, Batioglu F. Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol. 2004;48:386–91.PubMedCrossRefGoogle Scholar
  41. 41.
    Aung T, Okada K, Poinoosawmy D, et al. The phenotype of normal tension glaucoma patients with and without OPA1 polymorphisms. Br J Ophthalmol. 2003;87:49–152.CrossRefGoogle Scholar
  42. 42.
    Aysun S, Topcu M, Gunay M, et al. Neurologic features as the initial presentations of childhood malignancies. Pediatr Neurol. 1994;10:40–3.PubMedCrossRefGoogle Scholar
  43. 43.
    Babovic-Vuksanovic D, Snow K, Patterson MC, et al. Spinocerebellar ataxia type 2 (SCA2) in an infant with extreme CAG repeat expansion. Am J Med Genet. 1998;79:383–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Badea N. Crouzon’s disease. Oftalmologia. 1991;35:63–6.PubMedGoogle Scholar
  45. 45.
    Baker RH, Trautmann JC, Younge BR, et al. Late juvenile-onset Krabbe’s disease. Ophthalmology. 1990;97:1176–80.PubMedCrossRefGoogle Scholar
  46. 46.
    Bamashmus MA, Matlhaga B, Dutton GN. Causes of blindness and visual impairment in the West of Scotland. Eye. 2004;18:257–61.PubMedCrossRefGoogle Scholar
  47. 47.
    Ban T, Heymann JAW, Song Z, et al. OPA1 disease alleles causing dominant optic atrophy have defects in lipid binding, GTP hydrolysis, and membrane titubation. Hum Mol Genet. 2010;19: 2113–22.PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Banna M, Hoare RD, Stanley P, et al. Craniopharyngioma in children. J Pediatr. 1973;83:781–5.PubMedCrossRefGoogle Scholar
  49. 49.
    Barbet F, Gerber S, Hakiki S, et al. A first locus for isolated autosomal recessive optic atrophy (ROA1) maps to chromosome 8q. Eur J Hum Genet. 2003;11:966–71.PubMedCrossRefGoogle Scholar
  50. 50.
    Barbet F, Hakiki S, Orssaud C, et al. A third locus for dominat optic atrophy on chromosome 22q. J Med Genet. 2005;42:e1.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Barboni P, Carbonelli M, Savini G, et al. Natural history of Leber’s hereditary optic neuropathy: longitudinal analysis of retinal nerve fiber layer by optical coherence tomography. Ophthalmology. 2010;117:623–7.PubMedCrossRefGoogle Scholar
  52. 52.
    Barboni P, Savini G, Cascavilla ML, et al. Early macular retinal ganglion cell loss in dominant optic atrophy: genotype and phenotype correlation. Am J Ophthalmol. 2014;158:628–36.PubMedCrossRefGoogle Scholar
  53. 53.
    Barboni P, Savini G, Parisi V, et al. Retinal nerve fiber layer thickness in dominant optic atrophy. Measurements by optical coherence tomography and correlation with age. Arch Ophthalmol. 2011;118:2076–80.CrossRefGoogle Scholar
  54. 54.
    Barboni P, Valentino ML, Morgia CL, et al. Idebenone treatment in patients with OPA1-mutant dominant optic atrophy. Brain. 2013;136:1–5.CrossRefGoogle Scholar
  55. 55.
    Barkovich AJ. Pediatric neuroimaging. Philadelphia: Lippincott Williams and Wilkins; 2005. p. 231–439.Google Scholar
  56. 56.
    Barrett TG, Bundley SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet. 1995;346:1458–63.PubMedCrossRefGoogle Scholar
  57. 57.
    Barrientos A, Volpini V, Casademont J, et al. A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome. J Clin Invest. 1996;97:1570–6.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Bartels MC, Vaandrager JM, de Jong TH, et al. Visual loss in syndromic craniosynostosis with papilledema but without other symptoms of intracranial hypertension. J Craniofacial Surg. 2004;15:1019–22, discussion 1023–24.CrossRefGoogle Scholar
  59. 59.
    Bartlett JR. Craniopharyngiomas: summary of 85 cases. J Neurol Neurosurg Psychiatry. 1971;34:37–41.PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Basel-Vanagaite L, Straussberg R, Ovadia H, et al. Infantile bilateral striatal necrosis maps to chromosome 19q. Neurology. 2004;62:87–90.PubMedCrossRefGoogle Scholar
  61. 61.
    Baskin DS, Wilson CB. Surgical management of craniopharyngiomas: a review of 74 cases. J Neurosurg. 1986;65:22–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Beatty RM, Sadun AA, Smith L, et al. Direct demonstration of transsynaptic degeneration in the human visual system: a comparison of retrograde and anterograde changes. J Neurol Neurosurg Psychiatry. 1982;45:143–6.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Besch D, Kurtenbach A, Apfelstedt-Sylla E, et al. Visual field constriction and electrophysiological changes associated with vigabatrin. Doc Ophthalmol. 2002;104:151–70.PubMedCrossRefGoogle Scholar
  64. 64.
    Behr C. Die Komplizieric hereditar-familiare Optikusatrophie des kindesalters. Klin Mb Augenheilk. 1909;47:318.Google Scholar
  65. 65.
    Bell RA, Thompson HS. Relative afferent pupillary defect in optic tract hemianopias. Am J Ophthalmol. 1978;85:538–40.PubMedCrossRefGoogle Scholar
  66. 66.
    Benecke R, Berthold A, Conrad B. Denervation activity in the EMG of patients with upper motor neuron lesions: time course, local distribution and pathogenetic aspects. J Neurol. 1983;230: 143–51.PubMedCrossRefGoogle Scholar
  67. 67.
    Bénichou OD, Laredo JD, de Vernejoul MC. Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients. Bone. 2000;26:87–93.PubMedCrossRefGoogle Scholar
  68. 68.
    Bénit P, Siama A, Cartault F, et al. Mutant NDUFS3 subunit of mitochondrial complex 1 causes Leigh syndrome. J Med Genet. 2004;41:14–7.PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Bennett JL. Developmental neurogenetics and neuro-ophthalmology. J Neuroophthalmol. 2002;22:286–96.PubMedCrossRefGoogle Scholar
  70. 70.
    Bennett MJ, Gibson KM, Sherwood WG, et al. Reliable prenatal diagnosis of Canavan disease (aspartoacylase deficiency): comparison of enzymatic and metabolite analysis. J Inherit Metab Dis. 1993;16:831–6.PubMedCrossRefGoogle Scholar
  71. 71.
    Benomar A, Krols L, Stevanin G, et al. The gene for autosomal dominant cerebellar ataxia with pigmentary macular dystrophy maps to chromosome 3p12-21.1. Nat Genet. 1995;10:84–8.PubMedCrossRefGoogle Scholar
  72. 72.
    Berker N, Batman C, Guven A, et al. Optic atrophy and macular degeneration as initial presentations of subacute sclerosing panencephalitis. Am J Ophthalmol. 2004;138:879–81.PubMedCrossRefGoogle Scholar
  73. 73.
    Berman JL, Kashii S, Trachtman MS, et al. Optic neuropathy and central nervous system disease secondary to Sjogren’s syndrome in a child. Ophthalmology. 1990;97:1606–9.PubMedCrossRefGoogle Scholar
  74. 74.
    Berninger TA, Jaeger W, Krastel H. Electrophysiology and colour perimetry in dominant infantile optic atrophy. Br J Ophthalmol. 1991;75:49–52.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Bhattacharyya PC. Behr disease. J Assoc Physicians India. 1985;33:674–5.PubMedGoogle Scholar
  76. 76.
    Bhatti MT, Newman NJ. A multiple sclerosis-like illness in a man harboring the mtDNA 14484 mutation. J Neuroophthalmol. 1999;19:28–33.Google Scholar
  77. 77.
    Bieganski T, Baranska D, Miastkowska I, et al. A boy with severe craniodiaphysial dysplasia and apparently normal mother. Am J Hum Genet. 2007;143A:2435–43.Google Scholar
  78. 78.
    Bindu PS, Desai S, Shehanaz KE, et al. Clinical heterogeneity in Hallervorden–Spatz syndrome: a clinicoradiological study in 13 patients from South India. Brain Dev. 2006;28:343–7.PubMedCrossRefGoogle Scholar
  79. 79.
    Bindu PS, Mahadevan A, Taly AB, et al. Peripheral neuropathy in metachromatic leucodystrophy: a study of 40 cases from South India. J Neurol Neurosurg Psychiatry. 2005;76:1698–701.PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Bitouin P, Martin-Pont B, Tamboise E, et al. Optic atrophy, microcephaly, mental retardation and mosaic variegated aneuploidy: a human mitotic mutation. Ann Genet. 1994;37:75–7.Google Scholar
  81. 81.
    Blazo MA, Lewis RA, Chintagumpala MM, et al. Outcomes of systematic screening for optic pathway tumors in children with neuro-fibromatosis type 1. Am J Med Genet. 2004;127A:224–9.PubMedCrossRefGoogle Scholar
  82. 82.
    Blohmé J, Tornqvist K. Visually impaired Swedish children. The 1980 cohort study: aspects on mortality. Acta Ophthalmol Scand. 2000;78:560–5.PubMedCrossRefGoogle Scholar
  83. 83.
    Bodunde OT, Ojibode HA. Congenital eye diseases at Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria. Niger J Med. 2006;15:291–4.PubMedGoogle Scholar
  84. 84.
    Boiko AN, Guseva ME, Guseva MR, et al. Clinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children. J Neurovirol. 2000;6 Suppl 2:S152–5.PubMedGoogle Scholar
  85. 85.
    Bonifert T, Karle KN, Tonagel F, et al. Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier. Brain. 2014;137:2164–77.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Borgna-Pignatti C, Marradi P, Pinelli L, et al. Thiamine-responsive anemia in DIDMOAD syndrome. J Pediatr. 1989;114:405–10.PubMedCrossRefGoogle Scholar
  87. 87.
    Borrett D, Becker LE. Alexander disease: a disease of astrocytes. Brain. 1985;108:367–85.PubMedCrossRefGoogle Scholar
  88. 88.
    Borruat FX, Green WT, Graham EM, Sweeney M, Morgan-Hughes JA, Sanders MD. Late onset Leber’s optic neuropathy: a case confused with ischaemic optic neuropathy. Br J Ophthalmol. 1992;76:571–5.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Borruat FX, Kawasaki A. Optic nerve massaging: an extremely rare cause of self-inflicted blindness. Am J Ophthalmol. 2005;139:715–6.PubMedCrossRefGoogle Scholar
  90. 90.
    Borruat FX, Schatz NJ, Glaser JS, et al. Visual recovery from radiation-induced optic neuropathy. The role of hyperbaric oxygen therapy. J Clin Neuroophthalmol. 1993;13:98–101.PubMedGoogle Scholar
  91. 91.
    Bosch DGM, Boonstra FN, Gonzaga-Jauregui C, et al. NR2F1 mutations cause optic atrophy with intellectual disability. Am J Hum Genet. 2014;94:303–9.PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Bosley TM, Brodsky M, Glasier CM, et al. Sporadic bilateral optic neuropathy in children: the role of mitochondrial abnormalities. Invest Ophthalmol Vis Sci. 2008;49:5250–6.PubMedCrossRefGoogle Scholar
  93. 93.
    Bosley TM, Salih MA, Alorainy IA, et al. The neurology of carbonic anhydrase type II deficiency syndrome. Brain. 2011;134: 3502–15.PubMedCrossRefGoogle Scholar
  94. 94.
    Bothe N, Lieb B, Schafer WD. Development of impaired vision in mentally handicapped children. Klin Monatsbl Augenheilkd. 1991;198:509–14.PubMedCrossRefGoogle Scholar
  95. 95.
    Boto-De-los-Bueis A. Late optic neuropathy in propionic academia following surgical intervention. J Neuroophthalmol. 2013;33:90–5.PubMedCrossRefGoogle Scholar
  96. 96.
    Bower SP, Hawley I, Mackey DA. Cardiac arrhythmia and Leber’s hereditary optic neuropathy. Lancet. 1992;339:1427–8.PubMedCrossRefGoogle Scholar
  97. 97.
    Bowman RJC, Wedner S, Bowman RF, et al. Optic neuropathy in secondary school children in Dar es Salaam, Tanzania. Br J Ophthalmol. 2010;94:146–9.PubMedCrossRefGoogle Scholar
  98. 98.
    Bozkurt B, Yildirim MS, Okka M, Birirgen G. GAPO syndrome: four new patients with congenital glaucoma and myelinated retinal nerve fiber layer. Am J Med Genet A. 2013;161A:829–34.PubMedCrossRefGoogle Scholar
  99. 99.
    Bracken MB, Holford TR. Effects of timing of methylprednisolone of naloxone administration on recovery of segmental and long-tract neurologic function in NASCIS 2. J Neurosurg. 1993;79:500–7.PubMedCrossRefGoogle Scholar
  100. 100.
    Bremner FD, Tomlin EA, Swhallo-Hoffmann J, et al. Comparing pupil function with visual function in patients with Leber’s hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 1999;40:2528–34.PubMedGoogle Scholar
  101. 101.
    Bristow EA, Griffiths PG, Andrews RM, et al. The distribution of mitochondrial activity in relation to optic nerve structure. Arch Ophthalmol. 2002;120:791–6.PubMedCrossRefGoogle Scholar
  102. 102.
    Brodsky MC, Fritz KJ. Elusive neuro-ophthalmic reading impairment. Am J Ophthalmol. 1992;42:159–64.Google Scholar
  103. 103.
    Brodsky MC. The “pseudo-CSF” signal of orbital optic glioma on magnetic resonance imaging: a signature of neurofibromatosis. Surv Ophthalmol. 1993;38(2):213–8.PubMedCrossRefGoogle Scholar
  104. 104.
    Brodsky MC. Periventricular leukomalacia: an intracranial cause of pseudoglaucomatous cupping. Arch Ophthalmol. 2001;119: 626–7.PubMedCrossRefGoogle Scholar
  105. 105.
    Brodsky MC, Fray KJ, Glasier CM. Perinatal cortical and subcortical visual loss: mechanisms of injury and associated ophthalmologic signs. Ophthalmology. 2002;109:85–94.PubMedCrossRefGoogle Scholar
  106. 106.
    Brodsky MC, Glasier CM, Pollock SC, et al. Optic nerve hypoplasia identification by magnetic resonance imaging. Arch Ophthalmol. 1990;108:1562–7.PubMedCrossRefGoogle Scholar
  107. 107.
    Brodsky MC, Hoyt WF, Barnwell SL, et al. Intrachiasmatic craniopharyngioma: a rare cause of chiasmal thickening. Case report. J Neurosurg. 1988;68(2):300–2.PubMedCrossRefGoogle Scholar
  108. 108.
    Brodsky MC, Hoyt WF, Newton DR. The “phantom” optic nerve: demonstration in CT and MR scans 19 years after resection of optic glioma. J Clin Neuroophthalmol. 1988;8:67–8.PubMedGoogle Scholar
  109. 109.
    Brookes JT, Kanis AB, Tan LY, et al. Cochlear implantation in deafness-dystonia-optic neuronopathy (DDON) syndrome. Int J Pediatr Otorhinolaryngol. 2008;72:121–6.PubMedCrossRefGoogle Scholar
  110. 110.
    Brown C. Infantile amyotrophic lateral sclerosis of the family type. J Nerv Ment Dis. 1894;19:707–16.CrossRefGoogle Scholar
  111. 111.
    Brown MD, Hosseini S, Steiner I, et al. Complete mitochondrial DNA sequence analysis in a family with early-onset dystonia and optic atrophy. Mov Disord. 2004;19:235–7.PubMedCrossRefGoogle Scholar
  112. 112.
    Brown MD, Zhadanov S, Allen JC, et al. Novel mtDNA mutations and oxidative phosphorylation dysfunction in Russian LHON families. Hum Genet. 2001;109:33–9.PubMedCrossRefGoogle Scholar
  113. 113.
    Brueton LA, Winter RM. Craniodiaphysial dysplasia. J Med Genet. 1990;27:701–6.PubMedPubMedCentralCrossRefGoogle Scholar
  114. 114.
    Brunette JR, Bernier G. Study of a family of Leber’s optic atrophy with recuperation. In: Brunette JR, Barbeau A, editors. Progress in neuro-ophthalmology. Amsterdam: Excerpta Medica; 1969. p. 91–7.Google Scholar
  115. 115.
    Bu X, Rotter JI. Wolfram syndrome: a mitochondrial-mediated disorder? Lancet. 1993;342:598–600.PubMedCrossRefGoogle Scholar
  116. 116.
    Buchfelder M, Macpherson P. CT appearances of craniopharyngiomas before and after therapy. Zentralbl Neurochirurg. 1986;47:89–94.Google Scholar
  117. 117.
    Bulbul Baskan E, Baykara M, Ercan I, et al. Vitiligo and ocular findings: a study on possible associations. J Eur Acad Dermatol Venereol. 2006;20:829–33.PubMedGoogle Scholar
  118. 118.
    Buncic JR. Ocular aspects of Apert syndrome. Clin Plast Surg. 1991;18:315–9.PubMedGoogle Scholar
  119. 119.
    Buncic JR, Westall CA, Panton CM, et al. Characteristic retinal atrophy with secondary “inverse” optic atrophy identifies vigabatrin toxicity in children. Ophthalmology. 2004;111:1935–42.PubMedCrossRefGoogle Scholar
  120. 120.
    Buono LM, Foroozan R. Perioperative posterior ischemic optic neuropathy: review of the literature. Surv Ophthalmol. 2005; 50(1):15–26.PubMedCrossRefGoogle Scholar
  121. 121.
    Burdett TC, Freeman MR. Astrocytes eyeball axonal mitochondria. Science. 2014;345:385–6.PubMedCrossRefGoogle Scholar
  122. 122.
    Bürk K, Abele M, Fetter M, et al. Autosomal dominant cerebellar ataxia type 1: clinical features and MRI in families with SCA1, SCA2, and SCA3. Brain. 1996;119:1497–505.PubMedCrossRefGoogle Scholar
  123. 123.
    Burke JP, O’Keefe M, Bowell R, et al. Ocular complications in homocystinuria—early and late treated. Br J Ophthalmol. 1989;73(6):427–31.PubMedPubMedCentralCrossRefGoogle Scholar
  124. 124.
    Burke JP, O’Keefe M, Bowell R, et al. Ophthalmic findings in maple syrup urine disease. Metab Pediatr Syst Ophthalmol. 1991;14:12–5.Google Scholar
  125. 125.
    Buttner N, Geschwind D, Jen JC, et al. Oculomotor phenotypes in autosomal dominant ataxias. Arch Neurol. 1998;55:1353–7.PubMedCrossRefGoogle Scholar
  126. 126.
    Byrd DJ, Krohn HP, Winkler L, et al. Neonatal pyruvate dehydrogenase deficiency with lipoate responsive lactic acidaemia and hyperammonaemia. Eur J Pediatr. 1989;148(6):543–7.PubMedCrossRefGoogle Scholar
  127. 127.
    Cabezudo JM, Perez C, Vaquero J, et al. Pubertas praecox in craniopharyngioma: case report. J Neurosurg. 1981;55:127–31.PubMedCrossRefGoogle Scholar
  128. 128.
    Cabezudo JM, Vaquero J, Garcia-de-Sola G, et al. Computed tomography with craniopharyngiomas: a review. Surg Neurol. 1981;15:422–7.PubMedCrossRefGoogle Scholar
  129. 129.
    Calogero JA, Alexander E. Unilateral amaurosis in a hydrocephalic child with an obstructed shunt: case report. J Neurosurg. 1971;34:236.PubMedCrossRefGoogle Scholar
  130. 130.
    Campana G, Valentini G, Legnaioli MI, et al. Ocular aspects in biotinidase deficiency. Clinical and genetic original studies. Ophthalmic Paediatr Genet. 1987;8:125–9.PubMedCrossRefGoogle Scholar
  131. 131.
    Cano A, Molines L, Valéro R, et al. Microvascular diabetes complications in Wolfram syndrome (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness [DIDMOAD]): an age- and duration-matched comparison with common type 1 diabetes. Diabetes Care. 2007;30:2327–30.PubMedCrossRefGoogle Scholar
  132. 132.
    Cano A, Rouzier C, Monnot S, et al. Identification of novel mutations in WFS1 and genotype-phenotype correlation in Wolfram syndrome. Am J Med Genet. 2007;143A:1605–12.PubMedCrossRefGoogle Scholar
  133. 133.
    Carango P, Funanage VL, Quirós RE, et al. Overexpression of DM20 messenger RNA in two brothers with Pelizaeus–Merzbacher disease. Ann Neurol. 1995;38:610–7.PubMedCrossRefGoogle Scholar
  134. 134.
    Carelli V, Franceschini F, Venturi S, et al. Grand rounds: could occupational exposure to n-hexane and other solvents precipitate visual failure in Leber hereditary optic neuropathy? Environ Health Perspect. 2007;115:113–5.PubMedCrossRefGoogle Scholar
  135. 135.
    Carelli V, Giordano C, d’Amati G. Pathogenic expression of homoplasmic mtDNA mutations needs a complex, nuclear-mitochondrial interaction. Trends Genet. 2003;19:257–62.PubMedCrossRefGoogle Scholar
  136. 136.
    Carelli V, La Morgia C, Sadun AA. Mitochondrial dysfunction in optic neuropathies: animal models and therapeutic options. Neurology. 2013;26:52–8.Google Scholar
  137. 137.
    Carelli V, La Morgia C, Valentino ML, et al. Idebenone treatment in Leber’s hereditary optic neuropathy. Brain. 2011;134:e188.PubMedCrossRefGoogle Scholar
  138. 138.
    Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23:53–89.PubMedCrossRefGoogle Scholar
  139. 139.
    Carelli V, Ross-Cisneros FN, Sadun AA. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int. 2002;40:573–84.PubMedCrossRefGoogle Scholar
  140. 140.
    Carelli V, Schimpf S, Fuhrmann N, et al. A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16. Hum Mol Genet. 2011;20:1893–905.PubMedCrossRefGoogle Scholar
  141. 141.
    Carelli V, Schimpf S, Valentino ML, et al. Dominant optic atrophy (DOA) and sensorineural hearing loss: clinical, biochemical, spectroscopic, and molecular genetic study of a large Italian pedigree linked to a new locus on chromosome 16. Neurology. 2007;68:A42.Google Scholar
  142. 142.
    Carroll AL, Sullivan TJ. Orbital involvement in cherubism. Clin Experiment Ophthalmol. 2001;29:38–40.PubMedCrossRefGoogle Scholar
  143. 143.
    Carroll WM, Kriss A, Baraitser M, et al. The incidence and nature of visual pathway involvement in Friedreich’s ataxia. A clinical and visual evoked potential study of 22 patients. Brain. 1980;103:413.PubMedCrossRefGoogle Scholar
  144. 144.
    Carta A, Carelli V, D’Adda T, et al. Human extraocular muscles in mitochondrial diseases: comparing chronic progressive external ophthalmoplegia with Leber’s hereditary optic neuropathy. Br J Ophthalmol. 2005;89:825–7.PubMedPubMedCentralCrossRefGoogle Scholar
  145. 145.
    Cassidy L, Stirling R, May K, et al. Ophthalmic complications of childhood medulloblastoma. Med Pediatr Oncol. 2000;34:43–7.PubMedCrossRefGoogle Scholar
  146. 146.
    Casteels I, Spileers W, Swinnen T, et al. Optic atrophy as the presenting sign in Hallervorden–Spatz syndrome. Neuropediatrics. 1994;25:265–7.PubMedCrossRefGoogle Scholar
  147. 147.
    Castelnau P, Zilbovicius M, Ribeiro MJ, et al. Striatal and pontocerebellar hypoperfusion in Hallervorden-Spatz syndrome. Pediatr Neurol. 2001;25:170–4.PubMedCrossRefGoogle Scholar
  148. 148.
    Castrillion-Oberndorfer G, Seeberger R, Bacon C, et al. GAPO syndrome associated with craniofacial vascular malformation. Am J Med Genet. 2010;152A:225–7.CrossRefGoogle Scholar
  149. 149.
    Castro FJ, Barrio J, Perena MF, et al. Uncommon ophthalmologic findings associated with Wolfram syndrome. Acta Ophthalmol Scand. 2000;78:118–9.PubMedCrossRefGoogle Scholar
  150. 150.
    Castro-Gago M, Rodriguez-Nunez A, Eiris J, et al. Familial agenesis of the corpus callosum: a new form. Arch Fr Pediatr. 1993;50:327–30.PubMedGoogle Scholar
  151. 151.
    Cerovski B, Barisi N, Vidovi T, et al. Bilateral amaurosis caused by Salmonella enteritidis infection. Coll Antropol. 2004;28: 927–30.PubMedGoogle Scholar
  152. 152.
    Chahal HS, Lam A, Khaderi SK. J Neuroophthalmol. 2013;33:92–3.CrossRefGoogle Scholar
  153. 153.
    Chan JW. Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol. 2003;48:12–38.PubMedCrossRefGoogle Scholar
  154. 154.
    Chan T, Bowell R, O’Keefe M, et al. Ocular manifestations in fetal alcohol syndrome. Br J Ophthalmol. 1991;75(9):524–6.PubMedPubMedCentralCrossRefGoogle Scholar
  155. 155.
    Chau TT, Bertrand D, Bruno D. Pigmentary retinopathy in two siblings with wolfram disease. Ret Cases Brief Rep. 2010;4: 150–3.CrossRefGoogle Scholar
  156. 156.
    Chaudhry NS, Ahmad FU, Whittington E, et al. Primary intrinsic chiasmal germinoma. J Neuroophthalmol. 2015;35:171–4.PubMedGoogle Scholar
  157. 157.
    Chaung KW, Kim SB, Park KD, et al. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain. 2006;129:2103–18.CrossRefGoogle Scholar
  158. 158.
    Chaussenot A, Bannwarth S, Rouzier C, et al. Neurologic features and genotype-phenotype correlation in Wolfram syndrome. Ann Neurol. 2011;69:501–8.PubMedCrossRefGoogle Scholar
  159. 159.
    Chelluri L, Jastremski MS. Bilateral optic atrophy after cardiac arrest in a patient with acute respiratory failure on positive pressure ventilation. Resuscitation. 1988;16:45–8.PubMedCrossRefGoogle Scholar
  160. 160.
    Chen AS, Kovach MJ, Herman K, et al. Clinical heterogeneity in autosomal dominant optic atrophy in two 3q28-qter linked central Illinois families. Genet Med. 2000;2:283–9.PubMedCrossRefGoogle Scholar
  161. 161.
    Chen S, Zhang Y, Wang Y, et al. A novel OPA1 mutation responsible for autosomal dominant optic atrophy with high frequency hearing loss in a Chinese family. Am J Ophthalmol. 2007;143: 186–8.PubMedCrossRefGoogle Scholar
  162. 162.
    Chen Y, Jia X, Wang P, et al. Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy. Mol Vis. 2013;19:292–302.PubMedPubMedCentralGoogle Scholar
  163. 163.
    Chen YR, Breidahl A, Chang CN. Optic nerve decompression in fibrous dysplasia: indications, efficacy, and safety. Plast Reconstr Surg. 1997;99:22–30; discussion 31–3.PubMedCrossRefGoogle Scholar
  164. 164.
    Cherninkova S, Tzekov H, Karakostov V. Comparative ophthalmologic studies on children and adults with craniopharyngiomas. Ophthalmologica. 1990;201(4):201–5.PubMedCrossRefGoogle Scholar
  165. 165.
    Chinnery PF, Johnson MA, Wardell TM, et al. The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol. 2000;48:188–93.PubMedCrossRefGoogle Scholar
  166. 166.
    Chinnery PF, Schon EA. Mitochondria. J Neurol Neurosurg Psychiatry. 2003;74:1188–99.PubMedPubMedCentralCrossRefGoogle Scholar
  167. 167.
    Chitayat D, Silver K, Azouz EM. Skeletal dysplasia, intracerebral calcifications, optic atrophy, hearing impairment, and mental retardation: nosology of dysosteosclerosis. Am J Med Genet. 1992;43:517–23.PubMedCrossRefGoogle Scholar
  168. 168.
    Christiansen SP, Fray KJ, Spencer T. Ocular outcomes in low birth weight premature infants with intraventricular hemorrhage. J Pediatr Ophthalmol Strabismus. 2002;39:157–65.PubMedGoogle Scholar
  169. 169.
    Chuenkongkaew WL, Lertrit P, Limwongse C, et al. An unusual family with Leber’s hereditary optic neuropathy and facioscapulohumeral muscular dystrophy. Eur J Neurol. 2005;12:388–91.PubMedCrossRefGoogle Scholar
  170. 170.
    Chuenkongkaew WL, Suphavilai R, Vaeusorn L, et al. Proportation of 11778 mutant mitochondrial DNA and clinical expression in a Thai population with Leber hereditary optic neuropathy. J Neuroophthalmol. 2005;25:173–5.PubMedCrossRefGoogle Scholar
  171. 171.
    Chung KW, Kim SB, Park KD, et al. Early onset severe and lateonset Charcot–Marie–Tooth disease with mitofusin 2 (MFN2) mutations. Brain. 2006;129:2103–18.PubMedCrossRefGoogle Scholar
  172. 172.
    Chutorian AM. Acute loss of vision in children. Rev Neurol. 2003;36:264–71.PubMedGoogle Scholar
  173. 173.
    Chutorian JW, Winterkorn J, Genner M. Anterior ischemic optic neuropathy in children: case reports and review of the literature. Pediatr Neurol. 2002;26:358–64.PubMedCrossRefGoogle Scholar
  174. 174.
    Cillino S, Anastasi M, Lodato G. Incomplete Wolfram syndrome: clinical and electrophysiologic study of two familial cases. Graefes Arch Clin Exp Ophthalmol. 1989;227:131–5.PubMedCrossRefGoogle Scholar
  175. 175.
    Clayton LM, Dévilé M, Punte T, et al. Retinal nerve fiber layer thickness in vigabatrin-exposed patients. Ann Neurol. 2011;69:849–54.CrossRefGoogle Scholar
  176. 176.
    Coats DK, Demmler GJ, Paysse EA, et al. Ophthalmologic findings in children with congenital cytomegalovirus infection. J AAPOS. 2000;4:110–6.PubMedCrossRefGoogle Scholar
  177. 177.
    Cockayne EA. Dwarfism with retinal atrophy and deafness. Arch Dis Child. 1946;21:52–4.PubMedCentralCrossRefGoogle Scholar
  178. 178.
    Cogan DG, Schulman J, Porter RJ, et al. Epileptiform ocular movements with methylmalonic aciduria and homocystinuria. Am J Ophthalmol. 1980;90:251–3.PubMedCrossRefGoogle Scholar
  179. 179.
    Cohen SM, Brown III FR, Martyn L, et al. Ocular histopathologic and biochemical studies of the cerebrohepatorenal syndrome (Zellweger’s syndrome) and its relationship to neonatal adrenoleukodystrophy. Am J Ophthalmol. 1992;95: 82–96.Google Scholar
  180. 180.
    Cohen SM, Green WR, De la Cruz ZC, et al. Ocular histopathologic studies of neonatal and childhood adrenoleukodystrophy. Am J Ophthalmol. 1992;95:82–96.Google Scholar
  181. 181.
    Cohn AC, Toomes C, Potter C, et al. Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations. Am J Ophthalmol. 2007;143:656–62.PubMedCrossRefGoogle Scholar
  182. 182.
    Collins ML, Traboulsi EI, Maumenee IH. Optic nerve head swelling and optic atrophy in the systemic mucopolysaccharidoses. Ophthalmology. 1990;97:1445–9.PubMedCrossRefGoogle Scholar
  183. 183.
    Colosimo A, Guida V, Rigoli L, et al. Molecular detection of novel WFS1 mutations in patients with Wolfram syndrome by a DHPLC-based assay. Hum Mutat. 2003;21:622–9.PubMedCrossRefGoogle Scholar
  184. 184.
    Comaish IF, Gorman C, Brimlow GM, et al. The effects of vigabatrin on electrophysiology and visual fields in epileptics: a controlled study with a discussion of possible mechanisms. Doc Ophthalmol. 2002;104:195–212.PubMedCrossRefGoogle Scholar
  185. 185.
    Copeliovitch L, Katz K, Arbel N, et al. Musculoskeletal deformities in Behr syndrome. J Pediatr Orthop. 2001;21:512–4.PubMedGoogle Scholar
  186. 186.
    Corbett JJ. Neuro-ophthalmologic complications of hydrocephalus and shunting procedures. Semin Neurol. 1986;6:111–23.PubMedCrossRefGoogle Scholar
  187. 187.
    Cordes FC. Optic atrophy in infancy, childhood and adolescence. Am J Ophthalmol. 1952;35:1272–84.PubMedCrossRefGoogle Scholar
  188. 188.
    Costeff H, Elpeleg O, Apter N, et al. 3-Methylglutaconic aciduria in “optic atrophy plus”. Ann Neurol. 1993;33(1):103–4.PubMedCrossRefGoogle Scholar
  189. 189.
    Costeff H, Gadoth N, Apter N, et al. A familial syndrome of infantile optic atrophy, movement disorder, and spastic paraplegia. Neurology. 1989;39:595–7.PubMedCrossRefGoogle Scholar
  190. 190.
    Costenbader FD, O’Rourk TR. Optic atrophy in childhood. J Pediatr Ophthalmol. 1968;5:77.Google Scholar
  191. 191.
    Courtney RJ, Pennesi ME. Interval spectral-domain optical coherence tomography and electrophysiology findings in neonatal adrenoleukodystrophy. JAMA Ophthalmol. 2013;131: 808–10.CrossRefGoogle Scholar
  192. 192.
    Craig JE, Hewitt AW, Dimasi DP, et al. The role of the MetLys optineurin variant in inherited optic nerve diseases. Br J Ophthalmol. 2006;90:1420–4.PubMedPubMedCentralCrossRefGoogle Scholar
  193. 193.
    Cullom ME, Hehler KL, Miller NR, et al. Leber’s hereditary optic neuropathy masquerading as tobacco-alcohol amblyopia. Arch Ophthalmol. 1993;111:1482–5.PubMedCrossRefGoogle Scholar
  194. 194.
    Cutler CM, Lee JS, Butman JA, et al. Long-term outcome of optic nerve encasement and optic nerve decompression in patients with fibrous dysplasia: risk factors for blindness and safety of observation. Neurosurgery. 2006;59:1011–7.PubMedGoogle Scholar
  195. 195.
    Da Y, Zhang X, Li F, et al. Posterior reversible encephalopathy syndrome in a Leber hereditary optic neuropathy patient with mitochondrial DNA 11778>A point mutation. J Neuroophthalmol. 2013;33:276–8.PubMedCrossRefGoogle Scholar
  196. 196.
    da Cunha Linhares S, Horta WG, Marques Júnior W. Spinocerebellar ataxia type 7 (SCA 7): family princeps history, genealogy, and geographical distribution. Arq Neuropsquiatr. 2006;64:222–7.CrossRefGoogle Scholar
  197. 197.
    Dailey RA. Optic nerve sheath meningiomas of childhood. Ophthalmol Clin North Am. 1991;4(3):519–29.Google Scholar
  198. 198.
    Daneshvar H, Racette L, Coupland SG, et al. Symptomatic and asymptomatic visual loss in patients taking vigabatrin. Ophthalmology. 1999;106:1792–8.PubMedCrossRefGoogle Scholar
  199. 199.
    Daroff RB. See-saw nystagmus. Neurology. 1965;15:874–7.PubMedCrossRefGoogle Scholar
  200. 200.
    David G, Abbas N, Stevanin G, et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet. 1997;17:65.PubMedCrossRefGoogle Scholar
  201. 201.
    David LR, Velotta E, Weaver Jr RG, et al. Clinical findings precede objective diagnostic testing in the identification of increased ICP in syndromic craniosynotosis. J Craniofac Surg. 2002;13: 767–680.Google Scholar
  202. 202.
    Davis PC, Hoffman Jr JC, Pearl GS, et al. CT evaluation of effects of cranial radiation therapy in children. Am J Neuroradiol. 1986;7:639–44.Google Scholar
  203. 203.
    de Amorim Garcia Filho CA, Gomes AH, de A Garcia Soares AC, de Amorim Garcia CA. Clinical features of 121 patients with diffuse unilateral subacute neuroretinitis. Am J Ophthalmol. 2012;153:743–9.PubMedCrossRefGoogle Scholar
  204. 204.
    de Baulny HO, Benoist JF, Rigai O, et al. Methymalonic and propionic acidemias: management and outcomes. J Inherit Metab Dis. 2005;28:415–23.PubMedCrossRefGoogle Scholar
  205. 205.
    Debray FG, Lambert M, Chevaller I, et al. Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases. Pediatrics. 2007;119:722–33.PubMedCrossRefGoogle Scholar
  206. 206.
    Debs R, Froissart R, Aubourg P, et al. Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review. J Inherit Metab Dis. 2013;36:859–68.PubMedCrossRefGoogle Scholar
  207. 207.
    DeCarlo DK, Nowakowski R. Causes of visual impairment among students at the Alabama School for the Blind. J Am Optom Assoc. 1999;70:647–52.PubMedGoogle Scholar
  208. 208.
    Defoort-Dhellemmes S, Moritz F, Boucha I, et al. Craniopharyngioma: ophthalmological aspects at diagnosis. J Pediatr Endocrinol Metab. 2006;19:321–4.PubMedGoogle Scholar
  209. 209.
    Delague V, Bareil C, Bouvagnet P, et al. A new autosomal recessive non-progressive congenital cerebellar ataxia associated with mental retardation, optic atrophy, and skin abnormalities (CAMOS) maps to chromosome 15q24-26 in a large consanguineous Lebanese Druze Family. Neurogenetics. 2002;4:23–7.PubMedCrossRefGoogle Scholar
  210. 210.
    Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000;26:207–10.PubMedCrossRefGoogle Scholar
  211. 211.
    Demirgüneş EF, Ersoy-Evans S, Karaduman A. GAPO syndrome with the novel features of pulmonary hypertension, ankyloglossia, and prognathism. Am J Med Genet A. 2009;149A:802–5.PubMedCrossRefGoogle Scholar
  212. 212.
    Demos MK, van van Karnebeek CDM, Ross CJD. A novel recurrent mutation in ATP1A3 causes CAPOS syndrome. Orphanet J Rare Dis. 2014;9:15. doi: 10.1186/1750-1172-9-15.PubMedPubMedCentralCrossRefGoogle Scholar
  213. 213.
    Desir J, Coppieters F, Van Regemorter N, et al. TMEM126A mutation in a Morrocan family with autosomal recessive optic atrophy. Mol Vis. 2012;18:1849–57.PubMedPubMedCentralGoogle Scholar
  214. 214.
    DeVivo DC. The expanding clinical spectrum of mitochondrial disease. Brain Dev. 1993;15:1–21.CrossRefGoogle Scholar
  215. 215.
    de Vries L, Lazar L, Phillip M. Craniopharyngioma: presentation and endocrine sequelae in 36 children. J Pediatr Endocrinol Metab. 2003;16:703–10.PubMedCrossRefGoogle Scholar
  216. 216.
    De Weerdt CJ, Went LN. Neurological studies in families with Leber’s optic atrophy. Acta Neurol Scand. 1971;47:541–4.PubMedCrossRefGoogle Scholar
  217. 217.
    Diamond GA, D’Amico RA, Axelrod FB. Optic nerve dysfunction in familial dysautonomia. Am J Ophthalmol. 1987;104:645–9.PubMedCrossRefGoogle Scholar
  218. 218.
    Di Fabio R, Santorelli F, Bertini E. Infantile onsent of childhood spinocerebellar ataxia type 2. Cerebellum. 2011;11:526–30.CrossRefGoogle Scholar
  219. 219.
    Di Gennaro G, Condoluci C, Casali C, et al. Epilepsy and polymicrogyria in Kabuki make-up (Niikawa-Kuroki) syndrome. Pediatr Neurol. 1999;21:566–8.PubMedCrossRefGoogle Scholar
  220. 220.
    Dillmann U, Heide G, Dietz B, et al. Hereditary motor and sensory neuropathy with spastic paraplegia and optic atrophy: report on a family. J Neurol. 1997;244:562–5.PubMedCrossRefGoogle Scholar
  221. 221.
    DiMauro S, De Vivo DC. Genetic heterogeneity in Leigh syndrome. Ann Neurol. 1996;40:5–7.PubMedCrossRefGoogle Scholar
  222. 222.
    Dimitratos SD, Stathakis DG, Nelson CA, et al. The location of human CASK at Xp11.4 identifies this gene as a candidate for X-linked optic atrophy. Genomics. 1998;51:309.CrossRefGoogle Scholar
  223. 223.
    Dineen J, Hendrickson A, Keating EG. Alterations of retinal inputs following striate cortex removal in adult monkey. Exp Brain Res. 1982;47:446–56.PubMedCrossRefGoogle Scholar
  224. 224.
    Dogulu CF, Kansu T, Seyrantepe V, et al. Mitochondrial DNA analysis in the Turkish Leber’s hereditary optic neuropathy population. Eye. 2001;15(Pt 2):183–8.PubMedCrossRefGoogle Scholar
  225. 225.
    Dohi MT, Bardell AM, Stefano N, et al. Optic atrophy in Marinesco-Sjogren syndrome: an additional ocular feature. Ophthalmic Paediatr Genet. 1993;14:5–7.CrossRefGoogle Scholar
  226. 226.
    Doll R, Natowicz MR, Schiffmann R, et al. Molecular diagnostics for myelin proteolipid protein gene mutations in Pelizaeus–Merzbacher disease. Am J Hum Genet. 1992;51:161–9.PubMedPubMedCentralGoogle Scholar
  227. 227.
    Domenèch E, Gomez-Zaera M, Nunes V. Wolfram/DIDMOAD syndrome, a heterogenic and molecularly complex neurodegenerative disease. Pediatr Endocrinol Rev. 2006;3:249–57.PubMedGoogle Scholar
  228. 228.
    Domenèch E, Kruyer H, Gómez C, et al. First prenatal diagnosis for Wolfram syndrome by molecular analysis of the WFS1 gene. Prenat Diagn. 2004;24:787–9.PubMedCrossRefGoogle Scholar
  229. 229.
    Dörfler A, Wanke I, Wiedemayer H, et al. Endovascular treatment of a giant aneurysm of the internal carotid artery in a child with visual loss: case report. Neuropediatrics. 2000;31:151–4.Google Scholar
  230. 230.
    Drack AV, Traboulsi EI, Maumenee IH. Progression of retinopathy in olivopontocerebellar atrophy with retinal degeneration. Arch Ophthalmol. 1992;110:712–3.PubMedCrossRefGoogle Scholar
  231. 231.
    Dracopoulos A, Widjaja E, Raybaud C, et al. Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms. Epilepsia. 2010;51:1297–304.PubMedCrossRefGoogle Scholar
  232. 232.
    Dreyer M, Rudiger HW, Bujara K, et al. The syndrome of diabetes insipidus, diabetes mellitus, optic atrophy, deafness, and other abnormalities (DIDMOAD-syndrome). Two affected sibs and a short review of the literature (98 cases). Klin Wochenschr. 1982;60:471–5.PubMedCrossRefGoogle Scholar
  233. 233.
    DuBois LG, Feldon SE. Evidence for a metabolic trigger for Leber’s hereditary optic neuropathy. A case report. J Clin Neuroophthalmol. 1992;12:15–6.PubMedGoogle Scholar
  234. 234.
    Dufek S, Feldkoetter M, Vidal E, et al. Anterior ischemic optic neuropathy in pediatric peritoneal dialysis: risk factors and therapy. Pediatr Nephrol. 2014;29:1249–57.PubMedCrossRefGoogle Scholar
  235. 235.
    Duman O, Balta G, Metinsoy M, et al. Unusual manifestation of subacute sclerosing panencephalitis: case with intracranial high-pressure symptoms. J Child Neurol. 2004;19:552–5.PubMedGoogle Scholar
  236. 236.
    Durbin S, Mirabella G, Buncic JR, Westall CA. Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy. Invest Ophthalmol Vis Sci. 2009; 50:4011–6.PubMedCrossRefGoogle Scholar
  237. 237.
    Durr A, Brice A, Lepage-Lezin A, et al. Autosomal dominant cerebellar ataxia type I linked to chromosome 12q (SCA2: spinocerebellar ataxia type 2). Clin Neurosci. 1995;3:12–6.PubMedGoogle Scholar
  238. 238.
    Dutton JJ. Gliomas of the anterior visual pathway. Surv Ophthalmol. 1994;38:427–52.PubMedCrossRefGoogle Scholar
  239. 239.
    Dutton JJ, Burde RM. Anterior ischemic optic neuropathy of the young. J Clin Neuroophthalmol. 1983;3(2):137–46.PubMedGoogle Scholar
  240. 240.
    Eckhardt SM, Hicks EM, Herron B, et al. New form of autosomal-recessive axonal hereditary sensory motor neuropathy. Pediatr Neurol. 1998;19:234–5.PubMedCrossRefGoogle Scholar
  241. 241.
    Edwards TL, Buttery RG, Mackey DA. Is second eye involvement in Leber’s hereditary optic neuropathy due to retro-chiasmal spread of apoptosis? Neuro-Ophthalmology. 2007;31:87–98.CrossRefGoogle Scholar
  242. 242.
    Egan RA, Weleber RG, Hogarth P, et al. Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallevorden–Spatz syndrome). Am J Ophthalmol. 2005;140:267–74.PubMedPubMedCentralCrossRefGoogle Scholar
  243. 243.
    Eiberg H, Hansen L, Kjer B, et al. Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WSF1 Gene. J Med Genet. 2006;43:435–40.PubMedPubMedCentralCrossRefGoogle Scholar
  244. 244.
    Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. BMJ. 1997;314:180–1.PubMedPubMedCentralCrossRefGoogle Scholar
  245. 245.
    el-Azazi M, Maim G, Forsgren M. Late ophthalmologic manifestations of neonatal herpes simplex virus infection. Am J Ophthalmol. 1990;109:1–7.PubMedCrossRefGoogle Scholar
  246. 246.
    Elberg H, Kjer B, Kjer P, et al. Dominant optic atrophy (OPAI) mapped to chromosome 3q region. I: linkage analysis. Hum Mol Genet. 1994;3:977–80.CrossRefGoogle Scholar
  247. 247.
    Eldevik OP, Blaivas M, Gabrielsen TO, et al. Craniopharyngioma: radiologic and histologic findings and recurrence. AJNR Am J Neuroradiol. 1996;17:1427–39.PubMedGoogle Scholar
  248. 248.
    Eliott D, Traboulsi EI, Maumenee IH. Visual prognosis in auto-somal dominant optic atrophy (Kjer type). Am J Ophthalmol. 1993;115(3):360–7.PubMedCrossRefGoogle Scholar
  249. 249.
    Ellouze S, Augistin S, Bouaita A, et al. Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction. Am J Hum Genet. 2008;83:373–87.PubMedPubMedCentralCrossRefGoogle Scholar
  250. 250.
    Elpeleg ON, Costeff H, Joseph A, et al. 3-Methylglutaconic aciduria in the Iraqi-Jewish “optic atrophy plus” (Costeff) syndrome. Dev Med Child Neurol. 1994;36:167–72.PubMedCrossRefGoogle Scholar
  251. 251.
    El-Shanti H, Lidral AC, Jarrah N, et al. Homozygosity mapping identifies an additional locus for Wolfram syndrome on chromosome 4q. Am J Hum Genet. 2000;66:1229–36.PubMedPubMedCentralCrossRefGoogle Scholar
  252. 252.
    Enevoldson TP, Sanders MD, Harding AE. Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy (a clinical and genetic study of eight families). Brain. 1994;117:445.PubMedCrossRefGoogle Scholar
  253. 253.
    Ersahin Y, Mutluer S, Guzelbag E. Intracranial hydatid cysts in children. Neurosurgery. 1993;33:219–24; (discussion):224–225.PubMedCrossRefGoogle Scholar
  254. 254.
    Esteitie N, Hinttala R, Wibom R, et al. Secondary metabolic effects in complex I deficiency. Ann Neurol. 2005;58:544–52.PubMedCrossRefGoogle Scholar
  255. 255.
    Eustis HS, Yaplee SM, Kogutt M, et al. Microspherophakia in association with the rhizomelic form of chondrodysplasia punctata. J Pediatr Ophthalmol Strabismus. 1990;27:237–41.PubMedGoogle Scholar
  256. 256.
    Farber MD. National Registry for the Blind in Israel: estimation of prevalence and incidence rates and causes of blindness. Opthalmic Epidemiol. 2003;10:267–77.CrossRefGoogle Scholar
  257. 257.
    Farina L, Nardocci N, Bruzzone MG, et al. Infantile neuroaxonal dystrophy: neuroradiological studies in 11 patients. Neuroradiology. 1999;41:376–80.PubMedCrossRefGoogle Scholar
  258. 258.
    Farooq O, Lincoff NS, Saikali N, et al. Novel treatment for radiation optic neuropathy with intravenous bevacizumab. J Neuroophthalmol. 2012;32:321–4.PubMedCrossRefGoogle Scholar
  259. 259.
    Farukhi F, Dakkouri C, Wang H, et al. Etiology of vision loss in ganglioside GM3 synthase deficiency. Ophthalmic Genet. 2006;27:89–91.PubMedCrossRefGoogle Scholar
  260. 260.
    Fauser S, Luberichs J, Besch D, et al. Sequence analysis of the complete mitochondrial genome in patients with Leber’s hereditary optic neuropathy lacking the three most common pathogenic DNA mutations. Biochem Biophys Res Commun. 2002;295:342–7.PubMedCrossRefGoogle Scholar
  261. 261.
    Fazzi E, Rossi M, Signorini S, et al. Leber’s congenital amaurosis: is there an autistic component? Dev Med Child Neurol. 2007;49:503–7.PubMedCrossRefGoogle Scholar
  262. 262.
    Fein-Levy C, Gorlick R, Meyers PA, et al. Ewing’s sarcoma in a patient with congenital optic atrophy. J Pediatr Hematol Oncol. 1998;20:577–9.PubMedCrossRefGoogle Scholar
  263. 263.
    Felicio AC, Godeiro-Junior C, Alberto LG. Familial Behr syndrome-like phenotype with autosomal dominant inheritance. Parkinsonism Related Dis. 2008;14:370–2.CrossRefGoogle Scholar
  264. 264.
    Ferguson FR, Critchley M. Leber’s optic atrophy and its relationship to the heredo-familial ataxias. J Neurol Psychopathol. 1928;9:120–32.PubMedPubMedCentralCrossRefGoogle Scholar
  265. 265.
    Fernandez RG, Munoz-Negrete FJ, Garcia-Martin B, et al. Bilateral optic atrophy in Kenny’s syndrome. Acta Ophthalmol (Copenh). 1992;70:135–8.CrossRefGoogle Scholar
  266. 266.
    Ferreira RC, Mierau GW, Bateman JB. Conjunctival biopsy in infantile neuroaxonal dystrophy. Am J Ophthalmol. 1997;123:264–6.PubMedCrossRefGoogle Scholar
  267. 267.
    Ferrer I, Campistol J, Tobena L, et al. Degenerescence systematisee optico-cochleo-dentelee. J Neurol. 1987;234(6):416–20.PubMedCrossRefGoogle Scholar
  268. 268.
    Field MJ, Grattan-Smith P, Piper SM, et al. PEHO and PEHO-like syndromes: report of five Australian cases. Am J Med Genet. 2003;122A:6–12.PubMedCrossRefGoogle Scholar
  269. 269.
    Filiano JJ, Goldenthal MJ, Mamourian AC, et al. Mitochondrial DNA depletion in Leigh syndrome. Pediatr Neurol. 2002;26: 239–42.PubMedCrossRefGoogle Scholar
  270. 270.
    Finger PT. Anti-VEGF Bevacizumab (Avastin) for radiation optic neuropathy. Am J Ophthalmol. 2007;143:335–8.PubMedCrossRefGoogle Scholar
  271. 271.
    Fink JK. The hereditary spastic paraplegias: nine genes and counting. Arch Neurol. 2003;60:1045–9.PubMedCrossRefGoogle Scholar
  272. 272.
    Fink JK. Hereditary spastic paraplegia: clinical principles and genetic advances. Semin Neurol. 2014;34:293–305.PubMedCrossRefGoogle Scholar
  273. 273.
    Finsterer J. Leigh and Leigh-like syndrome in children and adults. Pediatr Neurol. 2008;39:223–35.PubMedCrossRefGoogle Scholar
  274. 274.
    Finsterer J, Stollberger C, Kopsa W, et al. Wolff-Parkinson-White syndrome and isolated left ventricular abnormal trabeculation as a manifestation of Leber’s hereditary optic neuropathy. Can J Cardiol. 2001;17:464–6.PubMedGoogle Scholar
  275. 275.
    Fletcher WA, Imes RK, Hoyt WF. Chiasmal gliomas: appearance and long-term changes demonstrated by computerized tomography. J Neurosurg. 1986;65(2):154–9.PubMedCrossRefGoogle Scholar
  276. 276.
    Foley AR, Menezes MP, Pandraud A, et al. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain. 2014;137:44–56.PubMedCrossRefGoogle Scholar
  277. 277.
    Folz SJ, Trobe JD. The peroxisome and the eye. Surv Ophthalmol. 1991;35(5):353–68.PubMedCrossRefGoogle Scholar
  278. 278.
    Fortuna F, Barboni P, Liguori R, et al. Visual system involvement in patients with Friederich’s ataxia. Brain. 2009;132:116–23.PubMedCrossRefGoogle Scholar
  279. 279.
    Fraioli B, Ferrante L, Celli P. Pituitary adenomas with onset during puberty. Features and treatment. J Neurosurg. 1983;59(4):590–5.PubMedCrossRefGoogle Scholar
  280. 280.
    Francois J. Heredity in opthalmology. St Louis: CV Mosby; 1961. p. 508–9.Google Scholar
  281. 281.
    Francois J. Mode d’hérédité des héredo-dégénérescences du nerf Optique. J Genet Hum. 1966;15:147–220.PubMedGoogle Scholar
  282. 282.
    Francois J. Ocular manifestations in demyelinating disease. Adv Ophthalmol. 1979;39:1–36.PubMedGoogle Scholar
  283. 283.
    Fraser JA, Biousse V, Newman NJ. The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol. 2010;55:299–334.PubMedPubMedCentralCrossRefGoogle Scholar
  284. 284.
    Fraser JA, Biousse V, Newman NJ. The neuro-ophthalmology of mitochondrial disease. Prog Ret Res. 2010;55:299–334.Google Scholar
  285. 285.
    Freeman JW, Cox TA, Batnitzky S, et al. Carniopharyngioma simulating bilateral internal ophthalmoplegia. Arch Neurol. 1980;37:176–7.PubMedCrossRefGoogle Scholar
  286. 286.
    Friedberg EC. Xeroderma pigmentosum, Cockayne syndrome, helicases and DNA repair. Cell. 1992;128:1233–7.Google Scholar
  287. 287.
    Frisen L, Claesson M. Narrowing of the retinal arterioles in descending optic atrophy: a quantitative clinical study. Ophthalmology. 1984;91:1342.PubMedCrossRefGoogle Scholar
  288. 288.
    Fritz KJ, Brodsky MC. Elusive neuro-ophthalmic reading impairment. Am Orthop J. 1992;42:159–62.Google Scholar
  289. 289.
    Fukuoka H, Kanda Y, Ohta S, et al. Mutations in the WFS1 gene are a frequent cause of autosomal dominant nonsyndromic low-frequency hearing loss in Japanese. J Hum Genet. 2007;52:510–5.PubMedCrossRefGoogle Scholar
  290. 290.
    Funalot B, Reynier P, Vighetto A, et al. Leigh-like encephalomyelopathy accompanying Leber’s hereditary optic neuropathy. Ann Neurol. 2002;52:374–7.PubMedCrossRefGoogle Scholar
  291. 291.
    Fusco C, Frattini D, Panteghini C, Pascarella R, Garavaglia B. A case of infantile neuroaxonal dystrophy of neonatal onset. J Child Neurol. 2015;30:368–70.PubMedCrossRefGoogle Scholar
  292. 292.
    Galluzzi P, Filosomi G, Vallone IM, et al. MRI of Wolfram syndrome (DIDMOAD). Neuroradiology. 1999;41:729–31.PubMedCrossRefGoogle Scholar
  293. 293.
    Gamez J, Montane D, Martorell L, et al. Bilateral optic nerve atrophy in myotonic dystrophy. Am J Ophthalmol. 2001;131:398–400.PubMedCrossRefGoogle Scholar
  294. 294.
    Ganesh A, Al-Kindi A, Jain R, et al. The phenotypic spectrum of Baraitser-Winter syndrome: a new case and review of literature. J AAPOS. 2005;9:604–6.PubMedCrossRefGoogle Scholar
  295. 295.
    García-Silva MT, Matthijs G, Schollen E, et al. Congenital disorder of glycosylation (CDG) type Ie: a new patient. J Inherit Metab Dis. 2004;27:591–600.PubMedCrossRefGoogle Scholar
  296. 296.
    Gasch AT, Caruso RC, Kaler SG, et al. Menkes’ syndrome: ophthalmic findings. Ophthalmology. 2002;109:1477–83.PubMedCrossRefGoogle Scholar
  297. 297.
    Gascon GG, Ozand PT, Brismar J. Movement disorders in childhood organic acidurias. Clinical, neuroimaging, and biochemical correlations. Brain Dev. 1994;16:94–103.PubMedCrossRefGoogle Scholar
  298. 298.
    Gascon GG, Ozand PT, Mahdi A, et al. Infantile CNS spongy degeneration—14 cases: clinical update. Neurology. 1990;40:1876–82.PubMedCrossRefGoogle Scholar
  299. 299.
    Gaston H. Ophthalmic complications of spina bifida and hydrocephalus. Eye. 1991;5(pt 3):279–90.PubMedCrossRefGoogle Scholar
  300. 300.
    Gay C, Divry P, Macabeo V, et al. N-acetylaspartic aciduria clinical, biological and physiopathological study. Arch Fr Pediatr. 1991;48(6):409–13.PubMedGoogle Scholar
  301. 301.
    Geneviève D, Amiel J, Viot G, et al. Atypical findings in Kabuki syndrome: report of 8 patients in a series of 20 and review of the literature. Am J Med Genet. 2004;129A:64–8.PubMedCrossRefGoogle Scholar
  302. 302.
    Georgy BA, Snow RD, Brogdon BG, Wertlelecki W. Neuroradiologic findings in Marinesco–Sjogren syndrome. Am J Neuroradiol. 1998;19:281–3.PubMedGoogle Scholar
  303. 303.
    Ghose S. Optic nerve changes in hydrocephalus. Trans Ophthalmol Soc U K. 1983;103(Pt 2):217–20.PubMedGoogle Scholar
  304. 304.
    Gillis L, Kaye E. Diagnosis and management of mitochondrial diseases. Pediatr Clin North Am. 2002;49:203–19.PubMedCrossRefGoogle Scholar
  305. 305.
    Giordano C, Montopoli M, Perli E, et al. Oestrogens ameliorate mitochondrial dysfunction in Leber’s hereditary optic neuropathy. Brain. 2011;134:220–34.PubMedCrossRefGoogle Scholar
  306. 306.
    Giulano F, Bannwarth S, Monnot S, et al. Wolfram syndrome in French population: characterization of novel mutations and polymorphisms in the WFS1 gene. Hum Mutat. 2005;25:99–100.CrossRefGoogle Scholar
  307. 307.
    Gizicki R, Robert M-C, Gómez-López L, et al. Long-term visual outcome of methylmalonic aciduria and homocystinuria, cobalamin C type. Ophthalmology. 2014;121:381–6.PubMedCrossRefGoogle Scholar
  308. 308.
    Goddey NO, Oladokun OA, Andy E, et al. Eye lesions and onchocerciasis in a rural farm settlement in Delta State, Nigeria. J Commun Dis. 2001;33:185–91.PubMedGoogle Scholar
  309. 309.
    Goebel H. Symposium: the neuronal ceroid-lipofuscinoses (NCL)-a group of lysosomal disorders come of age. Introduction. Brain Pathol. 2004;14:59–60.CrossRefGoogle Scholar
  310. 310.
    Goebel H, Wisniewski K. Symposium: the neuronal ceroid-lipofuscinoses (NCL): a group of lysosomal storage diseases come of age current state of clinical and morphological features in human NCL. Brain Pathol. 2004;14:61–9.PubMedCrossRefGoogle Scholar
  311. 311.
    Goizet C, Espil-Taris C, Husson M, et al. A patient with hydraencephaly and PEHO-like dysmorphic features. Ann Genet. 2003;461:25–8.CrossRefGoogle Scholar
  312. 312.
    Goldberg MF, Custis PH. Retinal and other manifestations of incontinenti pigmenti (Bloch-Sulzberger syndrome). Ophthalmology. 1993;100:1645–54.PubMedCrossRefGoogle Scholar
  313. 313.
    Goldberg MF, Scott CI, McKusick VA. Hydrocephalus and papilledema in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Am J Ophthalmol. 1970;69:969–75.PubMedCrossRefGoogle Scholar
  314. 314.
    Goldenberg-Cohen N, Miller NR, Repka MX. Traumatic optic neuropathy in children and adolescents. J AAPOS. 2004;8:20–7.PubMedCrossRefGoogle Scholar
  315. 315.
    Gonzalez P, Sills GJ, Parks S, et al. Binasal visual defects are not specific to vigabatrin. Epilepsy Behav. 2009;16:521–6.PubMedCrossRefGoogle Scholar
  316. 316.
    Good WV. Measuring field loss in children administered vigabatrin: a problem in search of a solution. J AAPOS. 2011;15: 411–2.PubMedCrossRefGoogle Scholar
  317. 317.
    Good WV, Hoyt CS, Lambert SR. Optic nerve atrophy in children with hypoxia. Invest Ophthalmol Vis Sci. 1987;28 (Suppl):309.Google Scholar
  318. 318.
    Goodman SJ, Rosenbaum AL, Hasso A, et al. Large optic nerve glioma with normal vision. Arch Ophthalmol. 1975;93:991–5.PubMedCrossRefGoogle Scholar
  319. 319.
    Gordon N. Canavan disease: a review of recent developments. Eur J Paediatr Neurol. 2001;5:65–9.PubMedCrossRefGoogle Scholar
  320. 320.
    Gordon N. Pantothenate kinase-associated neurodegeneration (Hallervorden-Spatz syndrome). Eur J Paediatr Neurol. 2002;6:243–7.PubMedCrossRefGoogle Scholar
  321. 321.
    Gotah Y, Machida S, Tazawa Y. Selective loss of the photopic negative response in patients with primary optic nerve atrophy. Arch Ophthalmol. 2004;122:341–6.CrossRefGoogle Scholar
  322. 322.
    Gourie-Devi M, Nalini A. Madras motor neuron disease variant: clinical features of seven patients. J Neurol Sci. 2003;209:13–7.PubMedCrossRefGoogle Scholar
  323. 323.
    Gouw LG, Digre KB, Harris CP, et al. Autosomal dominant cerebellar ataxia with retinal degeneration. A clinical and ocular histopathologic study. Neurology. 1994;44:1441.PubMedCrossRefGoogle Scholar
  324. 324.
    Gouw LG, Kaplan CD, Haines JH, et al. Retinal degeneration characterizes a spinocerebellar ataxia mapping to chromosome 3p. Nat Genet. 1997;17:65.CrossRefGoogle Scholar
  325. 325.
    Graham Jr JM, Anyane-Yeboa K, Raams A, et al. Cerebro-oculofacio-skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene with prenatal diagnosis in a triplet pregnancy. Am J Hum Genet. 2001;69:291–300.PubMedCrossRefGoogle Scholar
  326. 326.
    Graham Jr JM, Hennekam R, Dobyns WB, et al. MICRO syndrome: an entity distinct from COFS syndrome. Am J Med Genet. 2004;30:235–45.CrossRefGoogle Scholar
  327. 327.
    Gränse L, Bergstrand I, Thiselton D, et al. Electrophysiology and ocular blood flow in a family with dominant optic nerve atrophy and a mutation of the OPA1 gene. Ophthalmic Genet. 2003;24:233–45.PubMedCrossRefGoogle Scholar
  328. 328.
    Grant WM. Toxicology of the eye. 3rd ed. Springfield: Charles C. Thomas; 1986. p. 1048–9.Google Scholar
  329. 329.
    Grattan-Smith PJ, Healey S, Grigg JR, et al. Spinocerebellar ataxia type 7: a distinctive form of autosomal dominant cerebellar ataxia with retinopathy and marked genetic anticipation. J Paediatr Child Health. 2001;37:81–4.PubMedCrossRefGoogle Scholar
  330. 330.
    Gray TL, Casey T, Selva D, et al. Ophthalmologic sequelae of Crouzon syndrome. Ophthalmology. 2005;112:1129–34.PubMedCrossRefGoogle Scholar
  331. 331.
    Grazina MM, Diogo LM, Garcia PC. Atypical presentation of Leber’s hereditary optic neuropathy associated to mtDNA 11778G>A point mutation: a case report. Eur J Paediatr Neurol. 2007;11:115–8.PubMedCrossRefGoogle Scholar
  332. 332.
    Gripp KW, Hopkins E, Johnston JJ, Krause C, Dobyns WB, Biesecker LG. Long-term survival in TARP syndrome and confirmation of RBM10 as the disease-causing gene. Am J Med Genet A. 2011;155A:2516–20.PubMedCrossRefGoogle Scholar
  333. 333.
    Groom M, Kay MD, Corrent GF. Optic neuropathy in familial dysautonomia. J Neuroophthalmol. 1997;17:101–2.PubMedCrossRefGoogle Scholar
  334. 334.
    Grönlund MA, Honarvar AKS, Andersson S, et al. Ophthalmological findings in children and young adults with genetically verified mitochondrial disease. Br J Ophthalmol. 2010;94:121–7.PubMedCrossRefGoogle Scholar
  335. 335.
    Gropman AL. The neurological presentations of childhood and adult mitochondrial disease: established syndromes and phenotypic variations. Mitochondrion. 2004;4:503–20.PubMedCrossRefGoogle Scholar
  336. 336.
    Gropman A, Chen TJ, Perng CL, et al. Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation. Am J Med Genet. 2004;124A:377–82.PubMedCrossRefGoogle Scholar
  337. 337.
    Grosse-Aldenhovel HB, Gallenkamp U, et al. Juvenile onset diabetes mellitus, central diabetes insipidus and optic atrophy (Wolfram syndrome)—neurological findings and prognostic implications. Neuropediatrics. 1991;22:103–6.PubMedCrossRefGoogle Scholar
  338. 338.
    Grzybowski A, Zülsdorff M, Wilhelm H, Tonagel F. Toxic optic neuropathies: an updated review. Acta Ophthalmol. 2015;93:402–10.Google Scholar
  339. 339.
    Gücüyener K, Ozgül K, Paternotte C, et al. Autosomal recessive spastic ataxia of Charlevoix–Saguenay in two unrelated Turkish families. Neuropediatrics. 2001;32:142–6.PubMedCrossRefGoogle Scholar
  340. 340.
    Gupta S, Ghose S, Rohatgi M, et al. The optic nerve in children with craniosynostosis. A pre and post surgical evaluation. Doc Ophthalmol. 1993;83:271–8.PubMedCrossRefGoogle Scholar
  341. 341.
    Gupta DK, Suri A, Mahapatra AK, et al. Intracranial Rosai–Dorfman disease in a child mimicking bilateral giant petroclival meningiomas: a case report and review of literature. Childs Nerv Syst. 2006;22:1194–200.PubMedCrossRefGoogle Scholar
  342. 342.
    Gürtler M, Kim Y, Mhatre A, et al. Two families with nonsyndromic low-frequency hearing loss harbor novel mutations in Wolfram syndrome gene 1. J Mol Med. 2005;83:553–60.PubMedCrossRefGoogle Scholar
  343. 343.
    Gustayson KH, Anneren G, Malmgren H, et al. New X-linked syndrome with severe mental retardation, severely impaired vision, severe hearing defect, epileptic seizures, spasticity, restricted joint mobility, and early death. Am J Med Genet. 1993;45:654–8.CrossRefGoogle Scholar
  344. 344.
    Gutenberg A, Bell JJ, Lupi I, et al. Pituitary and systemic autoimmunity in a case of intrasellar germinoma. Pituitary. 2011;14: 388–94.PubMedCrossRefGoogle Scholar
  345. 345.
    Guy J, Feuer WJ, Porciatti V, et al. Retinal ganglion cell dysfunction in asymptomatic G11778A: Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2014;55:841–8.PubMedPubMedCentralCrossRefGoogle Scholar
  346. 346.
    Guy J, Mancuso A, Beck R, et al. Radiation-induced optic neuropathy: a magnetic resonance imaging study. J Neurosurg. 1991;74:426–32.PubMedCrossRefGoogle Scholar
  347. 347.
    Guy WM, Soparkar CNS, Alford EL, et al. Traumatic optic neuropathy and second optic nerve injuries. JAMA Ophthalmol. 2014;132:567–71.PubMedCrossRefGoogle Scholar
  348. 348.
    Haberland C, Brunngraber EG, Witting LA. Infantile neuroaxonal dystrophy. Arch Neurol. 1972;66:391–402.CrossRefGoogle Scholar
  349. 349.
    Haddad MA, Lobato FJ, Sampaio MW, et al. Pediatric and adolescent population with visual impairment: study of 385 cases. Clinics. 2006;61:239–46.PubMedCrossRefGoogle Scholar
  350. 350.
    Haddad MA, Sei M, Sampaio MW, Kara-José N. Causes of visual impairment in children: a study of 3, 210 cases. J Pediatr Ophthalmol Strabismus. 2007;44:232–40.PubMedGoogle Scholar
  351. 351.
    Haddad R, Font RL, Friendly DS. Cerebro-hepato-renal syndrome of Zellweger. Ocular histopathologic findings. Arch Ophthalmol. 1976;94:1927–30.PubMedCrossRefGoogle Scholar
  352. 352.
    Hadidy AM, Jarrah NS, Al-Till MI, et al. Radiological findings in Wolfram syndrome. Saudi Med J. 2004;25:638–41.PubMedGoogle Scholar
  353. 353.
    Haefell RH, Erb M, Gemperli AC, et al. NQOD1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels. PLoS One. 2011;6:e17963.CrossRefGoogle Scholar
  354. 354.
    Haftel LT, Lev D, Barash V, et al. Familial mitochondrial intestinal pseudo-obstruction and neurogenic bladder. J Child Neurol. 2000;15:386–90.PubMedCrossRefGoogle Scholar
  355. 355.
    Hagemoser K, Weinstein J, Bresnick G, et al. Optic atrophy, hearing loss, and peripheral neuropathy. Am J Med Genet. 1989;33(1):61–5.PubMedCrossRefGoogle Scholar
  356. 356.
    Haines SJ, Erickson DL, Wirtschafter JD. Optic nerve decompression for osteopetrosis in early childhood. Neurosurgery. 1988;23:470–5.PubMedCrossRefGoogle Scholar
  357. 357.
    Haines SR, Longmuir RA. Optic neuropathy due to biotinidase deficiency in a 19-year-old man. JAMA Ophthalmol. 2014;132:228–30.PubMedCrossRefGoogle Scholar
  358. 358.
    Haltia M, Somer M. Infantile cerebello-optic atrophy. Neuropathology of the progressive encephalopathy syndrome with edema, hypsarrhythmia and optic atrophy (the PEHO syndrome). Acta Neuropathol. 1993;85(3):241–7.PubMedCrossRefGoogle Scholar
  359. 359.
    Hamed LM. Retrograde transsynaptic degeneration of the retinogeniculate pathway after postnatal cerebral damage. Ophthalmology. 1994;101(Suppl):134. Abstract.Google Scholar
  360. 360.
    Hamed LM, Maria B, Quisling R, et al. Suprasellar lesions of maldevelopmental origin in Klinefelter’s syndrome. J Clin Neuroophthalmol. 1992;12(3):192–7.PubMedGoogle Scholar
  361. 361.
    Hamed LM, Purvin V, Rosenberg M. Recurrent anterior ischemic optic neuropathy in young adults. J Clin Neuroophthalmol. 1988;8:239–46.PubMedCrossRefGoogle Scholar
  362. 362.
    Hamid R, Sarkar S, Hossain MA, et al. Clinical picture of craniopharyngioma in childhood. Mymensingh Med J. 2007;16:123–6.PubMedGoogle Scholar
  363. 363.
    Hamilton SR. Neuro-ophthalmologic manifestations of the spinocerebellar degenerative disorders. In: Proceedings of the North American Neuro-ophthalmology Society. Snowmass, Colo., March 14–18; 1999. p. 195–203.Google Scholar
  364. 364.
    Hamilton SR, Chatrian GE, Mills RP, et al. Cone dysfunction in a subgroup of patients with autosomal dominant cerebellar ataxia. Arch Ophthalmol. 1990;108:551.PubMedCrossRefGoogle Scholar
  365. 365.
    Hammerstein W, Jurgens H, Gobel U. Retinal degeneration and embryonal rhabdomyosarcoma of the thorax. Fortschr Ophthalmol. 1991;88:463–5.PubMedGoogle Scholar
  366. 366.
    Hammond EJ, Wilder BJ. Evoked potentials in olivopontocerebellar atrophy. Arch Neurol. 1983;40:366–9.PubMedCrossRefGoogle Scholar
  367. 367.
    Hand CK, Bernard G, Dubé MP, et al. A novel PLP1 mutation further expands the clinical heterogeneity at the locus. Can J Neurol Sci. 2012;39:220–4.PubMedCrossRefGoogle Scholar
  368. 368.
    Hanemann CO, Hefter H, Schlaug G, et al. Characterization of basal ganglia dysfunction in Leber “plus” disease. J Neurol. 1996;243:297–300.PubMedCrossRefGoogle Scholar
  369. 369.
    Hansen E, Flage T, Rosenberg T, et al. Visual impairment in Nordic children. III: diagnoses. Acta Ophthalmol Copenh. 1992;70:597–604.Google Scholar
  370. 370.
    Hansen L, Eiberg H, Barrett T, et al. Mutation analysis of the WFS1 gene in seven Danish Wolfram syndrome families: four new mutations identified. Eur J Hum Genet. 2005;13: 1275–84.PubMedCrossRefGoogle Scholar
  371. 371.
    Hansen RM, Eklund SE, Benador IY, et al. Retinal degeneration in children: dark adapted visual threshold and arteriolar diameter. Vision Res. 2008;48:325–31.PubMedCrossRefGoogle Scholar
  372. 372.
    Harding AE. The clinical features and classification of late onset autosomal dominant cerebellar ataxias: a study of 11 families, including descendants of the “Drew family of Walworth”. Brain. 1982;105:1–28.PubMedCrossRefGoogle Scholar
  373. 373.
    Harding AE. The hereditary ataxias and related disorders. London: Churchill Livingstone; 1984.Google Scholar
  374. 374.
    Harding GF, Wild JM, Robertson KA, et al. Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction. Epilepsia. 2000;41:1420–31.PubMedCrossRefGoogle Scholar
  375. 375.
    Harding GF, Wild JM, Robertson KA, et al. Separating the retinal and electrophysiologic effects of vigabatrin: treatment versus field loss. Neurology. 2000;55:347–52.PubMedCrossRefGoogle Scholar
  376. 376.
    Hardy C, Khanim F, Torres R, et al. Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am J Hum Genet. 1999;65:1279–90.PubMedPubMedCentralCrossRefGoogle Scholar
  377. 377.
    Harley RD, Huang NM, Macri CH, et al. Optic neuritis and optic atrophy following chloramphenicol in cystic fibrosis patients. Trans Am Acad Ophthalmol Otollaryngol. 1970;74:1011–31.Google Scholar
  378. 378.
    Harrison DA, Mullaney PB, Mesfer SA, et al. Management of ophthalmic complications of homocystinuria. Ophthalmology. 1998;105:1886–90.PubMedCrossRefGoogle Scholar
  379. 379.
    Hassan A, Crompton JL, Sandhu H. Traumatic chiasmal syndrome: a series of 19 patients. Clin Exp Ophthalmol. 2002;30: 273–80.CrossRefGoogle Scholar
  380. 380.
    Hayasaka S, Yamaguchi K, Mizuno K, et al. Ocular findings in childhood lactic acidosis. Arch Ophthalmol. 1986;104:1656–8.PubMedCrossRefGoogle Scholar
  381. 381.
    Hayashi N, Geraghty MT, Green WR. Ocular histopathologic study of a patient with the T 8993-G point mutation in Leigh’s syndrome. Ophthalmology. 2000;107:1397–402.PubMedCrossRefGoogle Scholar
  382. 382.
    Hayati AA, Wan-Hitam WH, Cheong MT, et al. Optic neuritis in a child with biotinidase deficiency: case report and literature review. Clin Ophthalmol. 2012;6:389–95.PubMedPubMedCentralGoogle Scholar
  383. 383.
    Heher KL, Johns DR. A maculopathy associated with the 15257 mitochondrial DNA mutation. Arch Ophthalmol. 1993;111: 1495–8.PubMedCrossRefGoogle Scholar
  384. 384.
    Heidary G, Calderwood L, Cox GF, et al. Optic atrophy and a Leigh-like syndrome due to mutations in the C12orf65 gene: report of a novel mutation and review of the literature. J Neuroophthalmol. 2014;34:39–43.PubMedCrossRefGoogle Scholar
  385. 385.
    Heimer G, Sadaka Y, Israelian L, et al. CAOS-episodic cerebellar ataxia, areflexia, optic atrophy, and sensorineural hearing loss: a third allelic disorder of the ATP1A3 gene. J Child Neurol. 2015;30(13):1749–56. doi: 10.1177/0883073815579708.
  386. 386.
    Heng JE, Vorwerk CK, Lessell E, et al. Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway. Invest Ophthalmol Vis Sci. 1999;40:190–6.PubMedGoogle Scholar
  387. 387.
    Higgins JJ, Nee LE, Vasconcelos O, et al. Mutations in American families with spinocerebellar ataxia (SCA) type 3: SCA3 is allelic to Machado-Joseph disease. Neurology. 1996;46:208–13.PubMedCrossRefGoogle Scholar
  388. 388.
    Hildebrand GD, Russell-Eggitt I, Sanders D. Bow-tie cupping: a new sign of chiasmal compression. Arch Ophthalmol. 2010;128: 1625–6.PubMedCrossRefGoogle Scholar
  389. 389.
    Hirai T, Arai M, Ito Y, Sato M. Modified Bagolini striated glass test: clinical applications of starlight test in binocular visual field screening. Br J Ophthalmol. 1998;82:1288–93.PubMedPubMedCentralCrossRefGoogle Scholar
  390. 390.
    Hirai T, Ito Y, Arai M, et al. Loss of stereopsis with optic chiasmal lesions and stereoscopic tests as a differential test. Ophthalmology. 2002;209:1692–702.CrossRefGoogle Scholar
  391. 391.
    Hirai T, Kondo M, Takai Y, et al. Bagolini striated glasses test and lesions of the optic chiasm. Binocul Vis Strabismus Q. 2005;20:82–7.PubMedGoogle Scholar
  392. 392.
    Ho G, Walter JH, Christodoulou J. Costeff optic atrophy syndrome: new clinical case and novel molecular findings. J Inherit Med Dis. 2008, Epub ahead of print.Google Scholar
  393. 393.
    Hoekel J, Chisholm SA, Al-Lozi A, et al. Ophthalmologic correlates of disease severity in children and adolescents with Wolfram syndrome. J AAPOS. 2014;18:461–5.PubMedPubMedCentralCrossRefGoogle Scholar
  394. 394.
    Hoffmann A, Gebhardt U, Strekenberg AS, et al. Diencephalic syndrome in childhood craniopharyngioma—results of German multicenter studies on 485 long-term survivors of childhood craniopharyngioma. J Clin Endocrinol Metab. 2014;99:3972–7.PubMedCrossRefGoogle Scholar
  395. 395.
    Hofmann S, Bezold R, Jaksch M, et al. Wolfram (DIDMOAD) syndrome and Leber hereditary optic neuropathy (LHON) are assocaited with distinct mitochondrial haplotypes. Genomics. 1997;39:8–18.PubMedCrossRefGoogle Scholar
  396. 396.
    Hogarth P, Gregory A, Kruer MC, et al. New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN). Neurology. 2013;80:268–75.PubMedPubMedCentralCrossRefGoogle Scholar
  397. 397.
    Holmberg M, Johansson J, Forggren L, et al. Localization of autosomal dominant cerebellar ataxia associated with retinal degeneration and anticipation to chromosome 3p12-p21.1. Hum Mol Genet. 1995;10:89.Google Scholar
  398. 398.
    Houlden H, Smith S, DeCarvalho M, et al. Clinical and genetic characterization of families with triple A (Allgrove) syndrome. Brain. 2002;125:2681–90.PubMedCrossRefGoogle Scholar
  399. 399.
    Howell N. Mitochondrial gene mutations and human disease: a prolegomenon. Am J Hum Genet. 1994;55:219–24.PubMedPubMedCentralGoogle Scholar
  400. 400.
    Howell N, Halvorson S, Burns J, et al. When does bilateral optic atrophy become Leber hereditary optic neuropathy? Am J Hum Genet. 1993;53:959–63. Letter.PubMedPubMedCentralGoogle Scholar
  401. 401.
    Hoyt CS. Autosomal dominant optic atrophy: a spectrum of disability. Ophthalmology. 1980;87:245.PubMedCrossRefGoogle Scholar
  402. 402.
    Hoyt CS, Billson FA. Optic neuropathy in ketogenic diet. Br J Ophthalmol. 1979;63(3):191–4.PubMedPubMedCentralCrossRefGoogle Scholar
  403. 403.
    Hoyt CS, Billson FA. Visual loss in osteopetrosis. Am J Dis Child. 1979;133:955–8.PubMedGoogle Scholar
  404. 404.
    Hoyt WF. Ophthalmoscopy of the retinal nerve fibre layer in neuro-ophthalmologic diagnosis. Aust J Ophthalmol. 1976;4:14.CrossRefGoogle Scholar
  405. 405.
    Hoyt WF, Fletcher WA, Imes RK. Chiasmal gliomas. Appearance and long-term changes demonstrated by computerized tomography. Prog Exp Tumor Res. 1987;30:113–21.PubMedCrossRefGoogle Scholar
  406. 406.
    Hoyt CS, Good WV. Do we really understand the difference between optic nerve hypoplasia and atrophy? Eye. 1992;6(pt 2): 201–4.PubMedCrossRefGoogle Scholar
  407. 407.
    Hoyt WF, Imes RK. Optic gliomas of neurofibromatosis-1 (NF-1): contemporary perspectives. In: Ishibashi Y, Hori Y, editors. Tuberous sclerosis and neurofibromatosis: epidemiology, pathophysiology, biology and management. Amsterdam: Excerpta Medica; 1990. p. 239–46.Google Scholar
  408. 408.
    Hoyt WF, Rios-Montenegro EN, Behrens MM, et al. Homonymous hemioptic hypoplasia. Funduscopic features in standard and red-free illumination in three patients with congenital hemiplegia. Br J Ophthalmol. 1972;56:537–45.PubMedPubMedCentralCrossRefGoogle Scholar
  409. 409.
    Hoyt CS, Taylor D. Pediatric ophthalmology and strabismus. 4th ed. Edinburgh: Sanders Elsevier; 2013.Google Scholar
  410. 410.
    Hu Y, Chen IP, de Almeida S, et al. A novel autosomal recessive JGA1 missense mutation linked to craniometaphyseal dysplasia. PLoS. 2013;8:e73576Google Scholar
  411. 411.
    Huber A. Genetic diseases of vision. Curr Opin Neurol. 1994;7:65–8.PubMedCrossRefGoogle Scholar
  412. 412.
    Hudson G, Amati-Bonneau P, Blakely EL, et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain. 2008;131(Pt 2):329–37.PubMedCrossRefGoogle Scholar
  413. 413.
    Hudson G, Keers S, Yu Wai Man P, et al. Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigress. Am J Hum Genet. 2006;78:564–74.CrossRefGoogle Scholar
  414. 414.
    Huisman TA, Klein A, Werner B. Serial MR imaging, diffusion tensor imaging, and MR spectroscopic findings in a child with progressive encephalopathy, edema, hypsarrhythmia, and optic atrophy (PEHO) syndrome. AJNR Am J Neuroradiol. 2006;27: 1555–8.PubMedGoogle Scholar
  415. 415.
    Hull BM, Thompson DA. A review of the clinical applications of the pattern electroretinogram. Ophthalmic Physiol Opt. 1989;9:143–52.PubMedCrossRefGoogle Scholar
  416. 416.
    Huna-Baron R, Lesser RL, Warren FA, et al. Infantile cerebral aneurysms with visual pathway compression. Pediatr Neurosurg. 1999;31:322–5.PubMedCrossRefGoogle Scholar
  417. 417.
    Huo R, Burden SK, Hoyt CS, et al. Chronic cortical visual impairment in children: aetiology, prognosis, and associated neurological deficits. Br J Ophthalmol. 1999;83:670–5.PubMedPubMedCentralCrossRefGoogle Scholar
  418. 418.
    Huoponen K, Lamminen T, Juvonen V, et al. The spectrum of mitochondrial DNA mutations in families with Leber hereditary optic neuroretinopathy. Hum Genet. 1993;92:379–84.PubMedCrossRefGoogle Scholar
  419. 419.
    Hussain IHMI, Loh WF, Sofiah A. Childhood cerebral lupus in an Oriental population. Brain Dev. 1999;21:229–35.CrossRefGoogle Scholar
  420. 420.
    Hwang JM, Kim IO, Wang KC. Complete visual recovery in osteopetrosis by early optic nerve decompression. Pediatr Neurosurg. 2000;33:328–32.PubMedCrossRefGoogle Scholar
  421. 421.
    Hwang TN, McCulley TJ. A case of bilateral optic atrophy. In: Proceedings of the Frank B. Walsh Session. Feb. 11, 2007, Snowbird, UTGoogle Scholar
  422. 422.
    Ianchulev T, Kolin T, Moseley K, et al. Optic nerve atrophy in propionic acidemia. Ophthalmology. 2003;110:1850–4.PubMedCrossRefGoogle Scholar
  423. 423.
    Ichiyama T, Hayaski T, Unita T. Two possible cases of Alexander disease. Multimodal evoked potentials and MRI. Brain Dev. 1993;15:153–6.PubMedCrossRefGoogle Scholar
  424. 424.
    Ilker SS, Ozturk F, Kurt E, et al. Ophthalmic findings in GAPO syndrome. Jpn J Ophthalmol. 1999;43:48–52.PubMedCrossRefGoogle Scholar
  425. 425.
    Imes RK, Hoyt WF. Childhood chiasmal gliomas: update on the fate of patients in the 1969 study. Br J Ophthalmol. 1986;70: 179–82.PubMedPubMedCentralCrossRefGoogle Scholar
  426. 426.
    Imes RK, Hoyt WF. Magnetic resonance imaging signs of optic nerve gliomas in neurofibromatosis 1. Am J Ophthalmol. 1991;111:729–34.PubMedCrossRefGoogle Scholar
  427. 427.
    Ingelse J, Steele G. Characteristics of the pediatric/adolescent low-vision population at the Illinois School for the Visually Impaired. Optometry. 2001;72:761–6.PubMedGoogle Scholar
  428. 428.
    Inoue H, Tanizawa Y, Wasson J, et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet. 1998;20: 143–8.PubMedCrossRefGoogle Scholar
  429. 429.
    Ishikawa K, Funayama T, Ohde H, et al. Genetic variants of TP53 and EPHX1 in Leber’s hereditary optic neuropathy and their relationship to age at onset. Jpn J Ophthalmol. 2005;49: 121–6.PubMedCrossRefGoogle Scholar
  430. 430.
    Ishikawa T, Ito T, Shoji E, et al. Compressive optic nerve atrophy resulting from a distorted internal carotid artery. Pediatr Neurol. 2000;22:322–4.PubMedCrossRefGoogle Scholar
  431. 431.
    Ito S, Sakakibara R, Hattori T. Wolfram syndrome presenting with marked brain MR imaging abnormalities with few neurologic abnormalities. Am J Neuroradiol. 2007;28:305–6.PubMedGoogle Scholar
  432. 432.
    Iwashita H, Inoue N, Araki S, et al. Optic atrophy, neural deafness, and distal neurogenic amyotrophy. Report of a family with two affected siblings. Arch Neurol. 1970;22:357–64.PubMedCrossRefGoogle Scholar
  433. 433.
    Jacobson DM, Stone EM. Difficulty differentiating Leber’s from dominant optic neuropathy in a patient with remote visual loss. J Clin Neuroophthalmol. 1991;11:152–7.PubMedGoogle Scholar
  434. 434.
    Jacobson DM. Pupillary responses to dilute pilo-carpine in preganglionic 3rd nerve disorders. Neurology. 1990;40:804–8.PubMedCrossRefGoogle Scholar
  435. 435.
    Jacobson L, Hellström A, Flodmark O. Large cups in normal-sized optic discs. Arch Ophthalmol. 1997;115:1263–9.PubMedCrossRefGoogle Scholar
  436. 436.
    Jacobson SG, Aleman TS, Cideciyan AV, et al. Human cone photoreceptor dependence on RPE65 isomerase. Proc Natl Acad Sci U S A. 2007;104:15123–8.PubMedPubMedCentralCrossRefGoogle Scholar
  437. 437.
    Jakobiec FA, Depot MJ, Kennerdell JS, et al. Combined clinical and computed tomographic diagnosis of orbital glioma and meningioma. Ophthalmology. 1984;91:137–55.PubMedCrossRefGoogle Scholar
  438. 438.
    Jalil A, Usmani HA, Khan MI, et al. Bilateral paediatric optic neuropathy precipitated by vitamin B12 deficiency and a novel mitochondrial DNA mutation. Int Ophthalmol. 2013;33:687–90.PubMedCrossRefGoogle Scholar
  439. 439.
    Jampel RS, Okazaki H, Bernstein H. Ophthalmoplegia and retinal degeneration associated with spinocerebellar ataxia. Arch Ophthalmol. 1961;66:123.CrossRefGoogle Scholar
  440. 440.
    Jan JE, Robinson GC, Kinnis C, et al. Blindness due to optic nerve atrophy and hypoplasia in children: an epidemiology study (1944–1974). Dev Med Child Neurol. 1977;19:353.PubMedCrossRefGoogle Scholar
  441. 441.
    Jarc-Vidmar M, Tajnik M, Brecelj J, et al. Clinical and electrophysiology findings in Slovene patients with Leber hereditary optic neuropathy. Doc Ophthalmol. 2015;130:179–83.Google Scholar
  442. 442.
    Jensen ME, Sawyer RW, Braun IF, et al. MR imaging appearance of childhood adrenoleukodystrophy with auditory, visual, and motor pathway involvement. Radiographics. 1990;10:53–66.PubMedCrossRefGoogle Scholar
  443. 443.
    Jensen PK, Reske-Nielsen E, Hein-Sorenson O, et al. Syndrome of opticoacoustic nerve atrophy with dementia. Am J Med Genet. 1987;28:517–8.PubMedCrossRefGoogle Scholar
  444. 444.
    Jia X, Li S, Xiao X, et al. Molecular epidemiology of mtDNA mutations in 903 Chinese families suspected with Leber hereditary optic neuropathy. J Hum Genet. 2006;51:851–6.PubMedCrossRefGoogle Scholar
  445. 445.
    Jindahra P, Petrie A, Plant GT. Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain. 2009;132:628–34.PubMedCrossRefGoogle Scholar
  446. 446.
    Jindahra P, Petrie A, Plant GT. The time course of retrograde trans-synaptic degeneration following occipital lobe damage in humans. Brain. 2012;135:534–41.PubMedCrossRefGoogle Scholar
  447. 447.
    Johns DR, Heher KL, Miller NR, et al. Leber’s hereditary optic neuropathy: clinical manifestations of the 14484 mutation. Arch Ophthalmol. 1993;111:495–8.PubMedCrossRefGoogle Scholar
  448. 448.
    Johns DR, Neufeld MJ. Pitfalls in the molecular genetic diagnosis of Leber hereditary optic neuropathy (LHON). Am J Hum Genet. 1993;53:916–20.PubMedPubMedCentralGoogle Scholar
  449. 449.
    Johns DR, Smith KH, Miller NR. Leber’s hereditary optic neuropathy. Arch Ophthalmol. 1992;110:1577–81.PubMedCrossRefGoogle Scholar
  450. 450.
    Johns DR, Smith KH, Miller NR, et al. Identical twins who are discordant for Leber’s hereditary optic neuropathy. Arch Ophthalmol. 1993;111:1491–4.PubMedCrossRefGoogle Scholar
  451. 451.
    Johns DR, Smith KH, Savino PJ, et al. Leber’s hereditary optic neuropathy. Clinical manifestations of the 15257 mutation. Ophthalmology. 1993;100:981–6.PubMedCrossRefGoogle Scholar
  452. 452.
    Johnson AB. Alexander disease: a review and the gene. Int J Dev Neurosci. 2002;20:391–4.PubMedCrossRefGoogle Scholar
  453. 453.
    Johnston PB, Gastor RN, Smith VC, et al. A clinicopathologic study of autosomal dominant optic atrophy. Am J Ophthalmol. 1975;88:868–75.CrossRefGoogle Scholar
  454. 454.
    Johnston RL, Seller MJ, Behnam JT, et al. Dominant optic atrophy: refining the clinical diagnostic criteria in light of genetic linkage studies. Ophthalmology. 1999;106:123–8.PubMedCrossRefGoogle Scholar
  455. 455.
    Joseph M, Mendonca TM, Vasu U, et al. Paradoxical growth of presumed optochiasmatic tuberculomas following medical therapy. JAMA Ophthalmol. 2013;131:1463–7.PubMedCrossRefGoogle Scholar
  456. 456.
    Junck L, Fink JK. Machado-Joseph disease and SCA3: the genotype meets the phenotypes. Neurology. 1996;46:4–8.PubMedCrossRefGoogle Scholar
  457. 457.
    Jurkiewicz E, Mierzewska H, Bekiesi ska-Figatowska M, et al. MRI of a family with leukoencephalypathy with vanishing white matter. Pediatr Radiol. 2005;35:1027–30.PubMedCrossRefGoogle Scholar
  458. 458.
    Kalman B, Alder H. Is the mitochondrial DNA involved in determining susceptibility to multiple sclerosis? Acta Neurol Scand. 1998;98:232–7.PubMedCrossRefGoogle Scholar
  459. 459.
    Kalviainen R, Nousiainen I. Visual field defects with vigabatrin: epidemiology and therapeutic implications. CNS Drugs. 2001; 15:217–30.PubMedCrossRefGoogle Scholar
  460. 460.
    Kanamori A, Nakamura M, Yamada Y, Negi A. Longitudinal study of retinal nerve fiber layer thickness and ganglion cell complex in traumatic optic neuropathy. Arch Ophthalmol. 2012;130:1067–8.PubMedCrossRefGoogle Scholar
  461. 461.
    Kara B, Ayhan Ö, Gökçay G, Başboğaoğlu N, Tolun A. Adult phenotype and further phenotypic variability in SRD5A-3-CDG. BMC Med Genet. 2014;15:10.PubMedPubMedCentralCrossRefGoogle Scholar
  462. 462.
    Karzon RK, Hullar TE. Audiologic and vestibular findings in Wolfram syndrome. Ear Hear. 2013;34:809–12.PubMedPubMedCentralCrossRefGoogle Scholar
  463. 463.
    Käsmann-Kellner B, Jurin-Bunte B, Ruprecht KW. Incontentia pigmenti (Bloch–Sulzberger syndrome): case report and differential diagnosis-related dermato-ocular syndromes. Ophthalmologica. 1999;213:63–9.PubMedCrossRefGoogle Scholar
  464. 464.
    Käsmann-Kellner B, Weindler J, Pfau B, et al. Ocular changes in mucopolysaccharidosis IV A (Morquio syndrome) and long-term results of perforating keratoplasty. Ophthalmologica. 1999;213:200–5.PubMedCrossRefGoogle Scholar
  465. 465.
    Katz BJ, Zhao Y, Warner JE, et al. A family with X-linked optic atrophy linked to the OPA2 locus Xp11.4-Xp11.2. Am J Hum Genet. 2006;140A:2207–11.Google Scholar
  466. 466.
    Kaul R, Gao GP, Aloya M, et al. Canavan disease: mutations among Jewish and non-Jewish patients. Am J Hum Genet. 1994;55:34–41.PubMedPubMedCentralGoogle Scholar
  467. 467.
    Kawasaki A, Purvin VA. Photophobia as the presenting visual symptoms of chiasmal compression. J Neuroophthalmol. 2002;22:3–8.PubMedCrossRefGoogle Scholar
  468. 468.
    Kaye LC, Kaye SB, Lagnado R, et al. Cerebral arteriovenous malformation presenting as visual deterioration in a child. Dev Med Child Neurol. 2000;42:704–6.PubMedCrossRefGoogle Scholar
  469. 469.
    Kazek B, Jamroz E, Gencik M, et al. A novel PANK2 gene mutation: clinical and molecular characteristics of patients short communication. J Child Neurol. 2007;22:1256–9.PubMedCrossRefGoogle Scholar
  470. 470.
    Keltner JL, Thirkill CE. The 22-kDa antigen in optic nerve and retinal diseases. J Neuroopthalmol. 1999;19:71–83.Google Scholar
  471. 471.
    Kendall BE. Disorders of lysosomes, peroxisomes, and mitochondria. AJNR Am J Neuroradiol. 1992;13:621–53.PubMedGoogle Scholar
  472. 472.
    Kenyon KR. Ocular manifestations and pathology of systemic mucopolysaccharidoses. Birth Defects. 1976;XII:133–53.Google Scholar
  473. 473.
    Kerrison JB, Arnould VJ, Ferraz Sallum JM, et al. Genetic heterogeneity of dominant optic atrophy, Kjer type: identification of a second locus on chromosome 18q12.2-12.3. Arch Ophthalmol. 1999;117:805–10.PubMedCrossRefGoogle Scholar
  474. 474.
    Kerrison JB, Miller NR, Hsu F, et al. A case–control study of tobacco and alcohol consumption in Leber hereditary optic neuropathy. Am J Ophthalmol. 2000;130:803–12.PubMedCrossRefGoogle Scholar
  475. 475.
    Khan RI, O’Keefe M, Kenny D, et al. Changing pattern of childhood blindness. Ir Med J. 2007;100:458–61.PubMedGoogle Scholar
  476. 476.
    Khodadoust AA, Ziai M, Biggs SL. Optic disc in normal newborns. Am J Ophthalmol. 1968;66:502–4.PubMedCrossRefGoogle Scholar
  477. 477.
    Khong JJ, Anderson P, Gray TL, et al. Ophthalmic findings in Apert syndrome prior to craniofacial surgery. Am J Ophthalmol. 2006;142:328–30.PubMedCrossRefGoogle Scholar
  478. 478.
    Khong JJ, Anderson P, Gray TL, et al. Ophthalmic findings in Apert’s syndrome after craniofacial surgery: twenty-nine years’ experience. Ophthalmology. 2006;133:347–52.CrossRefGoogle Scholar
  479. 479.
    Kim CH, Oh DE, Kim YD. Bilateral visual loss in craniodiaphysial dysplasia. Am J Ophthalmol. 2006;141:398–9.PubMedCrossRefGoogle Scholar
  480. 480.
    Kim HJ, Sohn KM, Shy ME, et al. Mutations in PRPS1, which encodes the phosphoribosyl pyrophosphate synthetase enzyme critical for nucleotide biosynthesis, causes hereditary peripheral neuropathy with hearing loss and optic neuropathy (CMTX5). Am J Hum Genet. 2007;81:552–8.PubMedPubMedCentralCrossRefGoogle Scholar
  481. 481.
    Kim I, Ohnishi A, Kuroiwa Y. Three cases of Charcot-Marie-Tooth disease with neural deafness: the classification and sural nerve pathology. Rinsho Shinkeigaku. 1980;20:264–70.PubMedGoogle Scholar
  482. 482.
    Kim JW, Hills WL, Rizzo JF, et al. Ischemic optic neuropathy following spine surgery in a 16-year-old patient and a ten-year-old patient. J Neuroophthalmol. 2006;26(1):30–3.PubMedCrossRefGoogle Scholar
  483. 483.
    Kim JY, Hwang JM, Ko HS, et al. Mitochondrial DNA content is decreased in autosomal dominant optic atrophy. Neurology. 2005;64:966–72.PubMedCrossRefGoogle Scholar
  484. 484.
    Kim JY, Hwang JM, Park SS. Mitochondrial DNa C4171A/ND1 is a novel primary causative mutation of Leber’s hereditary optic neuropathy with a good prognosis. Ann Neurol. 2002;51:630–4.PubMedCrossRefGoogle Scholar
  485. 485.
    Kim TW, Hwang JM. Stratus OCT in dominant optic atrophy: features differentiating it from glaucoma. J Glaucoma. 2007;16:655–8.PubMedCrossRefGoogle Scholar
  486. 486.
    Kim KL, Park SP. Visual function test for early detection of ethambutol induced ocular toxicity at the subclinical level. Cut Ocul Toxicol. 2015;11:1–5.Google Scholar
  487. 487.
    Kimber J, McLean BN, Prevatt M, et al. Allgrove or 4 “A” syndrome: an autosomal recessive syndrome causing multisystem neurological disease. J Neurol Neurosurg Psychiatry. 2003;74: 654–7.PubMedPubMedCentralCrossRefGoogle Scholar
  488. 488.
    Kinder RS, Howard GM. Seesaw nystagmus. Am J Dis Child. 1963;106:331–2.PubMedCrossRefGoogle Scholar
  489. 489.
    King KM, Cronin C. Ocular findings in premature infants with grade IV intraventricular hemorrhage. J Pediatr Ophthalmol Strabismus. 1993;30:84–7.PubMedGoogle Scholar
  490. 490.
    Kinjo S, Takemoto M, Miyako K, et al. Two cases of Allgrove syndrome with mutations in the AAAS gene. Endocr J. 2004;51:473–7.PubMedCrossRefGoogle Scholar
  491. 491.
    Kinsley BT, Firth RG. The Wolfram syndrome: a primary neurodegenerative disorder with lethal potential. Ir Med J. 1992;85:34–6.PubMedGoogle Scholar
  492. 492.
    Kirkman MA, Yu-Wai-Man P, Korsten A. Gene-environment interactions in Leber hereditary optic neuropathy. Brain. 2009;132:2317–26.PubMedPubMedCentralCrossRefGoogle Scholar
  493. 493.
    Kirkham TH. The ocular symptomatology of pituitary tumours. Proc R Soc Med. 1972;65:517–8.PubMedPubMedCentralGoogle Scholar
  494. 494.
    Kjer P. Hereditary infantile optic atrophy with dominant transmission (preliminary report). Dan Med Bull. 1956;3:135–41.PubMedGoogle Scholar
  495. 495.
    Kjer P. Hereditary optic atrophies. The 1st Annual Hearst Lecture, presented at the 18th Annual Frederick C. Cordes Eye Society Meeting, University of California, San Francisco, CA, April 23, 1966.Google Scholar
  496. 496.
    Kjer P. Infantile optic atrophy with dominant mode of inheritance. A clinical and genetic study of 19 Dutch families. Acta Ophthalmol. 1959;164:1–147.Google Scholar
  497. 497.
    Kjer B, Eiberg H, Kjer B, et al. Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects. Acta Ophthalmol Scand. 1996;74:3–7.PubMedCrossRefGoogle Scholar
  498. 498.
    Kjer P, Jensen OA, Klinken L. Histopathology of eye, optic nerve and brain in a case of dominant optic atrophy. Acta Ophthalmol Copenh. 1983;61(2):300–12.PubMedCrossRefGoogle Scholar
  499. 499.
    Klein A, Schmitt B, Boltshauser E. Progressive encephalopathy with edema, hypsarrhythmia and optic atrophy (PEHO) syndrome in a Swiss child. Eur J Paediatr Neurol. 2004;8:317–21.PubMedCrossRefGoogle Scholar
  500. 500.
    Klein CJ, Kimmel GW, Pittock SJ, et al. Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria. Arch Neurol. 2011;68:1295–302.PubMedPubMedCentralCrossRefGoogle Scholar
  501. 501.
    Kleta R, Skovby F, Christensen E, et al. 3-Methylglutaconic aciduria type III in a non-Iraqi-Jewish kindred: clinical and molecular findings. Mol Genet Metab. 2002;76:201–6.PubMedCrossRefGoogle Scholar
  502. 502.
    Kline LB, Glaser JS. Dominant optic atrophy: the clinical profile. Arch Ophthalmol. 1979;97:1680–6.PubMedCrossRefGoogle Scholar
  503. 503.
    Klopstock T, Yu-Wai-Man P, Dimitriadis K, et al. A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy. Brain. 2011;134:2677–86.PubMedPubMedCentralCrossRefGoogle Scholar
  504. 504.
    Knape RM, Gandhi KB, Tuli SY, Khuddus N. Optic nerve findings in CHILD syndrome. J Pediatr Ophthalmol Strabismus. 2010;22:e1–3.Google Scholar
  505. 505.
    Kocur I, Resnikoff S. Visual impairment and blindness in Europe and their prevention. Br J Ophthalmol. 2002;86:716–22.PubMedPubMedCentralCrossRefGoogle Scholar
  506. 506.
    Koeppen AH. Friederich’s ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci. 2011;303:1–12.PubMedPubMedCentralCrossRefGoogle Scholar
  507. 507.
    Koeppen AH, Robitaille Y. Pelizaeus–Merzbacher disease. J Neuropathol Exp Neurol. 2002;61:747–59.PubMedCrossRefGoogle Scholar
  508. 508.
    Kohlschütter A, Shulz A, Denecke J. Epilepsy in neuronal ceroid lipofuscinosis. J Pediatric Epilepsy. 2014;3:199–206.Google Scholar
  509. 509.
    Koilkonda RD, Yu H, Chou T-H, et al. Safety and effects of the vector fot the Leber hereditary optic neuropathy gene therapy clinical trial. JAMA Ophthalmol. 2014;132:409–20.PubMedPubMedCentralCrossRefGoogle Scholar
  510. 510.
    Kojovic M, Parées I, Lampriea T, et al. The syndrome of deafness-dystonia: clinical and genetic heterogeneity. Mov Disord. 2013;28:795–803.PubMedCrossRefGoogle Scholar
  511. 511.
    Körner F. Non-visual control of human saccadic eye movements. In: Lennerstrad G, Bach-Y-Rita (Hrsg). Basic mechanisms of ocular motility and their clinical implications. Oxford: Pergamon Press, 1975. p. 565-9.Google Scholar
  512. 512.
    Kotb AA, Hammouda EF, Tabbara KF. Childhood blindness at a school for the blind in Riyadh, Saudi Arabia. Ophthalmic Epidemiol. 2006;13:1–5.PubMedCrossRefGoogle Scholar
  513. 513.
    Koul R, Chacko A, Ganesh A, et al. Vigabatrin associated retinal dysfunction in children with epilepsy. Arch Dis Child. 2001;85:469–73.PubMedPubMedCentralCrossRefGoogle Scholar
  514. 514.
    Krägeloh-Mann I, Grodd W, Niemann G, et al. Assessment and therapy monitoring of Leigh disease by MRI and proton spectroscopy. Pediatr Neurol. 1992;8:60–4.PubMedCrossRefGoogle Scholar
  515. 515.
    Krägeloh-Mann I, Toft P, Lunding J, et al. Brain lesions in preterms: origins, consequences and compensation. Acta Paediatr. 1999;88:897–908.PubMedCrossRefGoogle Scholar
  516. 516.
    Krauss GL, Johnson MA, Miller NR. Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology. 1998;50:614–8.PubMedCrossRefGoogle Scholar
  517. 517.
    Kretzer FL, Hittner HM, Mehta RS. Ocular manifestations of the Smith–Lemli–Opitz syndrome. Arch Ophthalmol. 1981;99: 2000–6.PubMedCrossRefGoogle Scholar
  518. 518.
    Kronenberg A, Blei F, Ceisler E, et al. Ocular and systemic manifestations of PHACES (Posterior fossa malformations, hemangiomas, arterial anomalies, cardiac defects and coarctation of the aorta, eye abnormalities, and sternal abnormalities or ventral developmental defects) syndrome. J AAPOS. 2005;9:169–73.PubMedCrossRefGoogle Scholar
  519. 519.
    Krumpaszky HG, Lüdtke R, Mickler A, et al. Blindness incidence in Germany: a population-based study from Württemberg–Hohenzollern. Ophthalmologica. 1992;213:176–82.CrossRefGoogle Scholar
  520. 520.
    Kumar N, Singh A, Saxena R, et al. An unusual cause of osteopetrosis in a child. Indian J Ophthalmol. 2014;62:494–5.PubMedPubMedCentralCrossRefGoogle Scholar
  521. 521.
    Kumar S. Wolfram syndrome: important implications for pediatricians and pediatric endocrinologists. Pediatr Diabetes. 2010;11:28–37.PubMedCrossRefGoogle Scholar
  522. 522.
    Kurian MA, McNeill A, Lin J-P, Maher ER. Childhood disorders of neurodegeneration with brain iron accumulation (NBIA). Dev Med Child Neurol. 2011;53:394–404.PubMedCrossRefGoogle Scholar
  523. 523.
    Kurian MA, Morgan NV, MacPherson L, et al. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology. 2008;70:1623–9.PubMedCrossRefGoogle Scholar
  524. 524.
    Kusuhara S, Nakamura M, Nagai-Kusuhara A, et al. Macular thickness reduction in eyes with unilateral optic atrophy detected with optical coherence tomography. Eye. 2006;20:882–7.PubMedCrossRefGoogle Scholar
  525. 525.
    Lagunju IA, Oluleye TS. Ocular abnormalities in children with cerebral palsy. Afr J Med Sci. 2007;36:71–5.Google Scholar
  526. 526.
    Lam BL, Feuer WJ, Schiffman JC, et al. Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy: preparation for gene therapy clinical trial. JAMA Ophthalmol. 2014;132:428–36.Google Scholar
  527. 527.
    Lambert SL, Hoyt C. Brain problems. In: Taylor D, editor. Pediatric ophthalmology. Boston: Blackwell Scientific Publications; 1990. p. 507.Google Scholar
  528. 528.
    Lambert SR, Hoyt CS, Jan JE, et al. Visual recovery from hypoxic cortical blindness during childhood. Computed tomographic and magnetic resonance imaging predictors. Arch Ophthalmol. 1987;105:1371–7.PubMedCrossRefGoogle Scholar
  529. 529.
    Lapresle J. Palatal myoclonus. Adv Neurol. 1986;43:265–73.PubMedGoogle Scholar
  530. 530.
    Larnaout A, Ben Hamida M, Hentati F. A clinicopathological observation of Nyssen-van Bogaert syndrome with second motor neuron degeneration: two distinct clinical entities. Acta Neurol Scand. 1998;98:452–7.PubMedCrossRefGoogle Scholar
  531. 531.
    Lavrov AY, Ilyna ES, Zakharova EY, et al. The first three Russian cases of classical, late-infantile, neuronal ceroid lipofuscinosis. Eur J Paediatr Neurol. 2002;6:161–4.PubMedCrossRefGoogle Scholar
  532. 532.
    Lawden M, Eke T, Degg C, Harding G, Wild J. Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry. 1999;67:716–22.PubMedPubMedCentralCrossRefGoogle Scholar
  533. 533.
    Lawthom C, Smith PE, Wild JM. Nasal retinal nerve fiber layer attenuation: a biomarker for vigabatrin toxicity. Ophthalmology. 2009;116:565–71.PubMedCrossRefGoogle Scholar
  534. 534.
    Leber T. Über hereditare und congenitalangelegte sehnervenleiden. Albrecht von Graefes Archiv Fuer Ophthalmol. 1871;17: 249–91.CrossRefGoogle Scholar
  535. 535.
    Leboulch P. Gene therapy: primed for take off. Nature. 2014;500:280–2.CrossRefGoogle Scholar
  536. 536.
    Lee AG, Sforza PD, Fard AK, et al. Pituitary adenoma in children. J Neuroophthalmol. 1998;18(2):102–5.PubMedCrossRefGoogle Scholar
  537. 537.
    Lee CW, Bang H, Oh YG, et al. A case of late infantile neuronal ceroid lipofuscinosis. Yonsei Med J. 2003;44:331–5.PubMedCrossRefGoogle Scholar
  538. 538.
    Lee HBH, Garrity JA, Cameron JD, et al. Primary optic nerve sheath meningioma in children. Surv Ophthalmol. 2008;53(6):543–58.CrossRefGoogle Scholar
  539. 539.
    Lee JS, FitzGibbon E, Butman JA, et al. Normal vision despite narrowing of the optic canal in fibrous dysplasia. N Engl J Med. 2002;247:1670–6.CrossRefGoogle Scholar
  540. 540.
    Lees F, MacDonald AM, Aldren Turner JW. Leber’s disease with symptoms resembling disseminated sclerosis. J Neurol Neurosurg Psychiatry. 1964;27:415–21.PubMedPubMedCentralCrossRefGoogle Scholar
  541. 541.
    Leeuwen MA, van Bogaert L. Hereditary ataxia with optic atrophy of the retrobulbar neuritis type, and latent pallido-Luysian degeneration. Brain. 1949;72:340.CrossRefGoogle Scholar
  542. 542.
    Lei SB, Wong A. A geriatric looking young boy. Presented at the Frank Walsh Society Meeting, February 22, 2009, Lake Tahoe, Nevada.Google Scholar
  543. 543.
    Leinonen MT, Elenius V. Perimetric testing of tritan deficiency. Ophthalmologica. 1992;204:204–9.PubMedCrossRefGoogle Scholar
  544. 544.
    Lenaers G, Hamel C, Delettre C, et al. Dominant optic atrophy. Orphanet J Rare Dis. 2012;7:46. doi: 10.1186/1750-1172-7-46.PubMedPubMedCentralCrossRefGoogle Scholar
  545. 545.
    Leshinsky-Silver E, Shuvalov R, Inbar S, et al. Juvenile Leigh syndrome, optic atrophy, ataxia, dystonia, and epilepsy due to T14487C mutation in the mtDNA-ND6 gene: a mitochondrial syndrome presenting from birth to adolescence. J Child Neurol. 2011;26:476–81.PubMedCrossRefGoogle Scholar
  546. 546.
    Lesperance MM, Hall III JW, San Agustin TB, et al. Mutations in the Wolfram syndrome type 1 gene (WFS1) define a clinical entity of dominant low-frequency sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 2003;129:411–20.PubMedCrossRefGoogle Scholar
  547. 547.
    Lessell S. Nutritional amblyopia. J Neuroophthalmol. 1998;18: 106–11.PubMedCrossRefGoogle Scholar
  548. 548.
    Lessell S, Rosman NP. Juvenile diabetes mellitis and optic atrophy. Arch Neurol. 1977;34:759.PubMedCrossRefGoogle Scholar
  549. 549.
    Leuzzi V, Bertini E, De-Negri AM, et al. Bilateral striatal necrosis, dystonia and optic atrophy in two siblings. J Neurol Neurosurg Psychiatry. 1992;55:16–9.PubMedPubMedCentralCrossRefGoogle Scholar
  550. 550.
    Levin LA, Beck RW, Joseph MP, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. Ophthalmology. 1999;106:1268–77.PubMedCrossRefGoogle Scholar
  551. 551.
    Levin LA, Beck RW, Joseph MP, et al. The treatment of traumatic optic neuropathy. The International Optic Nerve Trauma Study. Ophthalmology. 1999;106:1268–77.PubMedCrossRefGoogle Scholar
  552. 552.
    Levin LA. Superoxide generation explains common features of optic neuropathies associated with cecocentral scotomas. J Neuroophthalmol. 2015;35:152–60.PubMedPubMedCentralCrossRefGoogle Scholar
  553. 553.
    Levin ML, O’Conner PS, Aguirre G, et al. Angiographically normal central retinal artery following the total resection of an optic nerve glioma. J Clin Neuroophthalmol. 1986;6:1–8.PubMedCrossRefGoogle Scholar
  554. 554.
    Levin PS, Green WR, Victor DI, et al. Histopathology of the eye in Cockayne syndrome. Arch Ophthalmol. 1983;101:1093.PubMedCrossRefGoogle Scholar
  555. 555.
    Levy RL, Miller NR. Hyperbaric oxygen therapy for radiation-induced optic neuropathy. Ann Acad Med Singapore. 2006;35: 151–7.PubMedGoogle Scholar
  556. 556.
    Lewis RA, Gerson LP, Axelson KA, et al. Von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology. 1984;91:929–35.PubMedCrossRefGoogle Scholar
  557. 557.
    Li C, Kosmorsky G, Zhang K, et al. Optic atrophy and sensorineural hearing loss in a family caused by an R445H OPA1 mutation. Am J Med Genet. 2005;138A:208–11.PubMedCrossRefGoogle Scholar
  558. 558.
    Lieberman AP, Fischbeck KH. Triplet repeat expansion in neuromuscular disease. Muscle Nerve. 2002;23:843–50.CrossRefGoogle Scholar
  559. 559.
    Lin L, Chen Y, Tong Y, et al. Analysis of mitochondrial gene mutations in Chinese pedigrees of Leber’s hereditary optic neuropathy. Yan Ke Xue Bao. 2002;18:147–50.PubMedGoogle Scholar
  560. 560.
    Lindenbaum Y, Dickson D, Rosenbaum P, et al. Xeroderma pigmentosum/cockayne syndrome complex: first neuropathological study and review of eight other cases. Eur J Paediatr Neurol. 2001;5:225–42.PubMedCrossRefGoogle Scholar
  561. 561.
    Liskova P, Ulmanova O, Tesina P, et al. Novel OPA1 missense mutation in a family with optic atrophy and severe widespread neurological disorder. Acta Ophthalmol. 2013;91:e225–31.PubMedCrossRefGoogle Scholar
  562. 562.
    Listernick R, Charrow J, Greenwald MJ, et al. Optic gliomas in children with neurofibromatosis type 1. J Pediatr. 1989;114:788–92.PubMedCrossRefGoogle Scholar
  563. 563.
    Liu GT, Lessell S. Spontaneous visual improvement in chiasmal gliomas. Am J Ophthalmol. 1992;114:193–201.Google Scholar
  564. 564.
    Liu EM, Rajagopal R, Grand MG. Optic atrophy and hair loss in a young man. JAMA Ophthalmol. 2015;133:1470–1.Google Scholar
  565. 565.
    Livingstone IR, Mastaglia FL, Edis R, et al. Visual involvement in Friedreich ataxia and hereditary spastic ataxias: a clinical and visual response study. Arch Neurol. 1981;38:75–9.PubMedCrossRefGoogle Scholar
  566. 566.
    Lodi R, Tonon C, Valentino ML, et al. Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. Ann Neurol. 2004;56:719–23.PubMedCrossRefGoogle Scholar
  567. 567.
    Loeffler J, Utermann G, Witsch-Baumgartner M. Molecular prenatal diagnosis of Smith–Lemi–Opitz syndrome is reliable and efficient. Prenat Diagn. 2002;22:827–30.PubMedCrossRefGoogle Scholar
  568. 568.
    Longman C, Tolmie J, McWilliam R, et al. Cranial magnetic resonance imaging mistakenly suggests prenatal ischaemia in PEHO-like syndrome. Clin Dysmorphol. 2003;12:133–6.PubMedCrossRefGoogle Scholar
  569. 569.
    Longmuir SQ, Brodsky MC. Postnatal optic cupping in a non-glaucomatous infant with periventricular leukomalacia: nosologic implications. Br J Ophthalmol. 2012;96:607–8.Google Scholar
  570. 570.
    Lyons CJ, Castano G, McCormick AQ, Applegarth D. Leopard spot retinal pigmentation in infancy indicating a peroxisomal disorder. Br J Ophthalmol. 2004;88:191–2.PubMedPubMedCentralCrossRefGoogle Scholar
  571. 571.
    Lynch DR, Farmer J. Practical approaches to neurogenetic disease. J Neuroophthalmol. 2002;22:297–304.PubMedCrossRefGoogle Scholar
  572. 572.
    Ma J, Zhao C, Wang R, et al. Visual field improvement after pituitary tumor surgery in patients with McCune-Albright syndrome. J Neuroophthalmol. 2013;33:26–9.PubMedCrossRefGoogle Scholar
  573. 573.
    Mabuchi F, Tang SA, Kashiwagi K, et al. The OPA1 gene polymorphism is associated with normal tension and high tension glaucoma. Am J Ophthalmol. 2007;143:125–30.PubMedCrossRefGoogle Scholar
  574. 574.
    Macdermot KD, Walker RW. Autosomal recessive hereditary motor and sensory neuropathy with mental retardation, optic atrophy and pyramidal signs. J Neurol Neurosurg Psychiatry. 1987;50:1342–7.PubMedPubMedCentralCrossRefGoogle Scholar
  575. 575.
    Macedo-Souza LI, Kok F, Santos S, et al. Spastic paraplegia, optic atrophy, and neuropathy is linked to chromosome 11q13. Ann Neurol. 2005;57:730–7.PubMedCrossRefGoogle Scholar
  576. 576.
    Macedo-Souza LI, Kok F, Santos S, et al. Spastic paraplegia, optic atrophy, and neuropathy: new observations locus refinement, and exclusion of candidate genes. Ann Hum Genet. 2009;73:382–7.PubMedCrossRefGoogle Scholar
  577. 577.
    Mackenzie R, Klistorner A. Severe persistent visual field constriction associated with vigabatrin: asymptomatic as well as symptomatic defects occur with vigabatrin. BMJ. 1998;316:233.PubMedPubMedCentralGoogle Scholar
  578. 578.
    Mackey D, Howell N. A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology. Am J Hum Genet. 1992;51:1218–28.PubMedPubMedCentralGoogle Scholar
  579. 579.
    Mackey DA. Cardiac arrhythmias and Leber’s hereditary optic neuropathy. Lancet. 1992;339:1427–8.PubMedGoogle Scholar
  580. 580.
    Mackey DA, Buttery RG. Leber hereditary optic neuropathy in Australia. Aust N Z J Ophthalmol. 1992;20:177–84.PubMedCrossRefGoogle Scholar
  581. 581.
    Mackey DA, Fingert JH, Luzhansky JZ, et al. Leber’s hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virus. Eye. 2003;17:312–7.PubMedCrossRefGoogle Scholar
  582. 582.
    Mackey DA, Oostra RJ, Rosenberg T, et al. Primary pathogenic mtDNA mutations in multigenerational pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet. 1996;59:481–5.PubMedPubMedCentralGoogle Scholar
  583. 583.
    Madreperia SA. Olivopontocerebellar atrophy with retinal degeneration. Fundus characteristics and diagnostic MRI findings. Ophthalmic Pediatr Genet. 1993;14:61–8.CrossRefGoogle Scholar
  584. 584.
    Mafei L, Fiorrentini A. Electroretinographic responses to alternating gratings before and after section of the optic nerve. Science. 1981;211:953–5.PubMedCrossRefGoogle Scholar
  585. 585.
    Mafei L, Fiorrentini A, Bisti S, et al. Pattern ERG in the monkey after section of the optic nerve. Exp Brain Res. 1985;59:423–5.Google Scholar
  586. 586.
    Mahapatra AK. Optic nerve injury in children. A prospective study of 35 patients. J Neurol Sci. 1992;36:79–84.Google Scholar
  587. 587.
    Makhoul J, Cordonnier M, Van Nechel C. Optic neuropathy in Strumpell–Lorrain disease: presentation of a clinical case and literature review. Bull Soc Belge Ophtalmol. 2002;286:9–14.PubMedGoogle Scholar
  588. 588.
    Maksimova N, Hara K, Nikolaeva I, et al. Neuroblastoma amplified sequence gene is associated with a novel short stature syndrome characterized by optic atrophy and Pelger-Hüet anomaly. J Med Genet. 2010;47:538–48.PubMedPubMedCentralCrossRefGoogle Scholar
  589. 589.
    Man PY, Turnbull DM, Chinnery PF. Leber hereditary optic neuropathy. J Med Genet. 2002;39:162–9.PubMedCentralCrossRefGoogle Scholar
  590. 590.
    Manchester PT, Calhoun Jr FP. Dominant hereditary optic atrophy with bitemporal field defects. Arch Ophthalmol. 1958;60:479–84.CrossRefGoogle Scholar
  591. 591.
    Mansergh FC, Chadderton N, Kenna PF, et al. Cell therapy using retinal progenitor cells shows therapeutic effect in a chemically-induced rotenone mouse model of Leber hereditary optic neuropathy. Eur J Hum Genet. 2014;22:1314–20.PubMedPubMedCentralCrossRefGoogle Scholar
  592. 592.
    Mantyjarvi MI, Nerdrum K, Tuppurainen K. Color vision in dominant optic atrophy. J Clin Neuroophthalmol. 1992;12:98–103.PubMedGoogle Scholar
  593. 593.
    Margo C, Hamed LM, McCarty J. Congenital optic tract syndrome. Arch Ophthalmol. 1991;109:1120–2.PubMedCrossRefGoogle Scholar
  594. 594.
    Marszal E, Jamroz E, Paprocka J, et al. Leukoencephalopathy with macroencephaly and mild clinical course. Neurol Neurochir Pol. 2004;14:388.Google Scholar
  595. 595.
    Martin-Kleiner I, Gabrilovac J, Bradvica M, et al. Leber’s hereditary optic neuroretinopathy (LHON) associated with mitochondrial DNA point mutation G11778A in two Croatian families. Coll Antropol. 2006;30:171–4.PubMedGoogle Scholar
  596. 596.
    Maruyama K, Arisaka O, Lee T, et al. Optic atrophy in aqueduct stenosis. Eur J Pediatr. 1989;148:682. Letter.PubMedCrossRefGoogle Scholar
  597. 597.
    Marzan KA, Barron TF. MRI abnormalities in Behr syndrome. Pediatr Neurol. 1994;10:247–8.PubMedCrossRefGoogle Scholar
  598. 598.
    Mascalchi M, Salvi F, Piacentini S, Bartolozzi C. Friedreich’s ataxia: MR findings involving the cervical portion of the spinal cord. Am J Radiol. 1994;163:187–91.Google Scholar
  599. 599.
    Mashima Y, Kigasawa K, Hasegawa H, et al. High incidence of pre-excitation syndrome in Japanese families with Leber’s hereditary optic neuropathy. Clin Genet. 1996;50:535–7.PubMedCrossRefGoogle Scholar
  600. 600.
    Mashima Y, Sato EA, Ohde H, et al. Macular nerve fibers temporal to fovea may have a greater potential to recover function in patients with Leber’s hereditary optic neuropathy. Jpn J Ophthalmol. 2002;46:660–7.PubMedCrossRefGoogle Scholar
  601. 601.
    Matson DD, Crigler Jr JF. Management of craniopharyngioma in childhood. J Neurosurg. 1969;30(4):377–90.PubMedCrossRefGoogle Scholar
  602. 602.
    McAbee GN, Prieto DM, Kirby J, et al. Permanent visual loss due to dietary vitamin A deficiency in an autistic adolescent. J Child Neurol. 2009;24:1288–9.PubMedCrossRefGoogle Scholar
  603. 603.
    McAdams H, Geyer C, Done S, et al. CT and MR imaging of Canavan disease. Am J Neuroradiol. 1990;11:397–9.PubMedGoogle Scholar
  604. 604.
    McComas AJ. Invited review: motor unit estimation: methods, results, and present status. Muscle Nerve. 1991;14:585–97.PubMedCrossRefGoogle Scholar
  605. 605.
    McCorquodale 3rd DS, Montenegro G, Pequero A, et al. Mutation screening of mitofusin 2 in Charcot-Marie-Tooth disease type 2. J Neurol. 2011;258:1234–9.PubMedPubMedCentralCrossRefGoogle Scholar
  606. 606.
    McCoy B, Wright T, Weiss S, et al. Electroretinogram changes in a pediatric population with epilepsy: is vigabatrin acting alone? J Child Neurol. 2011;26:729–33.PubMedCrossRefGoogle Scholar
  607. 607.
    McDonnell JM, Green R, Maumenee IH. Ocular histopathology of systemic mucopolysaccharidosis. Opthalmology. 1990;97: 1445–9.CrossRefGoogle Scholar
  608. 608.
    McGinnity FG, Bryars JH. Controlled study of ocular morbidity in school children born preterm. Br J Ophthalmol. 1992;76: 520–4.PubMedPubMedCentralCrossRefGoogle Scholar
  609. 609.
    McKluskey DJ, O’Connor PS, Sheehy JT. Leber’s optic neuropathy and Charcot–Marie–Tooth disease. J Clin Neuroophthalmol. 1986;6:76–81.Google Scholar
  610. 610.
    Medlej R, Wasson J, Baz P, et al. Diabetes mellitus and optic atrophy: a study of Wolfram syndrome in the Lebanese population. J Clin Endocrinol Metab. 2004;89:1656–61.PubMedCrossRefGoogle Scholar
  611. 611.
    Mefty O, Fox JL, Al-Rodhan N, et al. Optic nerve decompression in osteopetrosis. J Neurosurg. 1988;68:80–4.CrossRefGoogle Scholar
  612. 612.
    Mégarbané A. Unknown diagnosis in two male cousins with facial abnormalities, optic atrophy, abnormal EEG, and severe psychomotor retardation. Am J Med Genet A. 2003;116A: 281–384.Google Scholar
  613. 613.
    Mégarbané A, Choueiri R, Bleik J, et al. Microcephaly, microphthalmia, congenital cataract, optic atrophy, short stature, hypotonia, severe psychomotor retardation, and cerebral malformations: a second family with micro syndrome or a new syndrome? J Med Genet. 1999;36:637–40.PubMedPubMedCentralGoogle Scholar
  614. 614.
    Mégarbané A, Delague V, Ruchoux MM, et al. New autosomal recessive cerebellar ataxia disorder in a large inbred Lebanese family. Am J Med Genet. 2001;101:135–41.PubMedCrossRefGoogle Scholar
  615. 615.
    Meier PG, Maeder P, Kardon RH. Homonymous ganglion cell layer thinning after isolated occipital lesion: macular OCT demonstrates transsynaptic retrograde retinal degeneration. J Neuroophthalmol. 2015;35:112–6.PubMedGoogle Scholar
  616. 616.
    Meira LB, Graham Jr JM, Greenberg CR, et al. Manitoba aboriginal kindred with original cerebro-oculo-facio-skeletal syndrome has a mutation in the Cockayne syndrome group B (CSB) gene. Am J Hum Genet. 2000;66:1221–8.PubMedPubMedCentralCrossRefGoogle Scholar
  617. 617.
    Meire F, De Laey JJ, de Bie S, et al. Dominant optic nerve atrophy with progressive hearing loss and chronic progressive external ophthalmoplegia (CPEO). Ophthalmic Paediatr Genet. 1985;5:91–7.PubMedCrossRefGoogle Scholar
  618. 618.
    Melo DR, Kowaltowski AJ, Wajner M, Castilho RF. Mitochondrial energy metabolism in neurodegeneration associated with methylmalonic acidemia. J Bioenerg Biomembr. 2011;43:39–46.PubMedCrossRefGoogle Scholar
  619. 619.
    Mendoza-Santiesteban CE, Hedges TE, Norcliffe-Kaufmann L, et al. Clinical neuro-ophthalmological findings in familial dysautonomia. J Clin Neuroophthalmol. 2013;32:23–6.CrossRefGoogle Scholar
  620. 620.
    Menkes JH, Alter M, Steigleder GK, et al. A sex-linked recessive disorder with grow retardation, peculiar hair, and focal cerebral and cerebellar degeneration. Pediatrics. 1962;29:764–79.PubMedGoogle Scholar
  621. 621.
    Menon V, Arya AV, Sharma P, et al. An aetiological profile of optic atrophy. Acta Ophthalmol Copenh. 1992;70:725–9.PubMedCrossRefGoogle Scholar
  622. 622.
    Merchant SN, McKenna MJ, Nadol Jr JB, et al. Temporal bone histopathologic and genetic studies in Mohr–Tranebjaerg syndrome (DFN-1). Otol Neurotol. 2001;22:506–11.PubMedCrossRefGoogle Scholar
  623. 623.
    Merrick J, Bergwerk K, Morad M, et al. Blindness in adolescents in Israel. Int J Adolesc Med Health. 2004;16:79–81.PubMedGoogle Scholar
  624. 624.
    Mets MB. Childhood blindness and visual loss: an assessment at two institutions including a “new” cause. Trans Am Ophthalmol Soc. 1999;97:653–96.PubMedPubMedCentralGoogle Scholar
  625. 625.
    Mets MB, Mhoon E. Probable autosomal dominant optic atrophy with hearing loss. Ophthalmic Paediatr Genet. 1985;5(1–2): 85–9.PubMedCrossRefGoogle Scholar
  626. 626.
    Meyer E, Michaelides M, Tee LJ, et al. Nonsense mutation in TMEM126A causing autosomal recessive optic atrophy and auditory neuropathy. Mol Vis. 2010;16:650–64.PubMedPubMedCentralGoogle Scholar
  627. 627.
    Michael CB, Lee AG, Patrinely JR, et al. Visual loss associated with fibrous dysplasia of the anterior skull base. Case report and review of the literature. J Neurosurg. 2000;92:350–4.PubMedCrossRefGoogle Scholar
  628. 628.
    Mikelberg FS, Yidegiligne HM. Axonal loss in band atrophy of the optic nerve in craniopharyngioma: a quantitative analysis. Can J Ophthalmol. 1993;28:69–71.PubMedGoogle Scholar
  629. 629.
    Milam AH, Barakat MR, Gupta N, et al. Clinicopathologic effects of mutant GUC Y2D in Leber congenital amaurosis. Ophthalmology. 2003;110:549–58.PubMedCrossRefGoogle Scholar
  630. 630.
    Milea D, Amati-Bonneau P, Reynier P, Bonneau D. Genetically determined optic neuropathies. Curr Opin Neurol. 2010;23: 24–8.PubMedCrossRefGoogle Scholar
  631. 631.
    Miller NR. Optic atrophy. In: Walsh FB, Hoyt WF, editors. Clinical neuro-ophthalmology. 4th ed. Baltimore: Williams & Wilkins; 1982. p. 329–42.Google Scholar
  632. 632.
    Miller NR. Radiation-induced optic neuropathy: still no treatment. Clin Experiment Ophthalmol. 2004;32:223–35.CrossRefGoogle Scholar
  633. 633.
    Miller NR, Newman SA. Transsynaptic degeneration. Arch Ophthalmol. 1981;99:165. Letter.Google Scholar
  634. 634.
    Miller NR, Solomon S. Retinochoroidal (optociliary) shunt veins, blindness, and optic atrophy: a nonspecific sign of chronic optic nerve compression. Aust NZ J Ophthalmol. 1991;19:105–9.CrossRefGoogle Scholar
  635. 635.
    Milone M, Benarroch EE. Mitochondrial dynamics: general concepts and clinical implications. Neurology. 2012;78:1612–9.PubMedCrossRefGoogle Scholar
  636. 636.
    Milone M, Benarroch EE, Wong L-J. POLG-related disorders: defects of the nuclear and mitochondrial genome interaction. Neurology. 2011;77:1847–52.PubMedCrossRefGoogle Scholar
  637. 637.
    Milone M, Wang J, Liewluck T, et al. Novel POLG splice site mutation and optic atrophy. Arch Neurol. 2011;68:806–11.PubMedCrossRefGoogle Scholar
  638. 638.
    Mirdehghan SA, Dehghan MH, Mohammadpour M, et al. Causes of severe visual impairment and blindness in schools for visually handicapped children in Iran. Br J Ophthalmol. 2005;89:612–4.PubMedPubMedCentralCrossRefGoogle Scholar
  639. 639.
    Miyake Y, Yagasaki K, Ichikawa H. Differential diagnosis of congenital tritanopia and dominantly inherited optic atrophy. Arch Ophthalmol. 1985;103:1496–501.PubMedCrossRefGoogle Scholar
  640. 640.
    Miyama S, Arimoto K, Kimiya S, et al. Complicated hereditary spastic paraplegia with peripheral neuropathy, optic atrophy and mental retardation. Neuropediatrics. 2000;31:214–7.PubMedCrossRefGoogle Scholar
  641. 641.
    Mnatsakanyan L, Ross-Cisneros FN, Carelli V, et al. Axonal degeneration in peripheral nerves in a case of Leber hereditary optic neuropathy. J Neuroophthalmol. 2011;31:6–11.PubMedPubMedCentralCrossRefGoogle Scholar
  642. 642.
    Mohn A, Capanna R, Delli Pizzi C, et al. Autosomal malignant osteopetrosis: from diagnosis to therapy. Minerva Pediatr. 2004;56:115–8.PubMedGoogle Scholar
  643. 643.
    Moll A, Orawiec B, Niwald A, et al. Causes of visual disability in children and young adults. Klin Oczna. 2005;107:93–5.PubMedGoogle Scholar
  644. 644.
    Moller HU. Recessively inherited, simple optic atrophy—does it exist? Ophthalmic Paediatr Genet. 1992;13:31–2. Letter.PubMedCrossRefGoogle Scholar
  645. 645.
    Monteiro ML. Evaluation of macular thickness measurements for detection of band atrophy of the optic nerve using optical coherence tomography. Ophthalmology. 2007;114:175–81.PubMedCrossRefGoogle Scholar
  646. 646.
    Moore AT, Buncic JR, Munro IR. Fibrous dysplasia of the orbit in childhood. Clinical features and management. Ophthalmology. 1985;92:12–20.PubMedCrossRefGoogle Scholar
  647. 647.
    Morava E, Rodenburg R, Hol F, et al. Mitochondrial dysfunction in Brooks–Wisniewski–Brown syndrome. Am J Med Genet. 2006;140:752–6.PubMedCrossRefGoogle Scholar
  648. 648.
    Morieira ES, Brasch NE, Yun J. Vitamin B12 protects against superoxide-induced cell injury in human aortic endothelial cells. Free Radic Biol Med. 2011;51:876–83.CrossRefGoogle Scholar
  649. 649.
    Moriya N, Mitsui T, Shibata T, et al. GAPOS syndrome: report on the first case in Japan. Am J Med Genet. 1995;58:257–61.PubMedCrossRefGoogle Scholar
  650. 650.
    Morris AA, Leonard JV, Brown GK, et al. Deficiency of respiratory chain complex I is a common cause of Leigh disease. Ann Neurol. 1996;40:25–30.PubMedCrossRefGoogle Scholar
  651. 651.
    Morse LE, Rosman NP. Myoclonic seizures in Krabbe disease: a unique presentation in late-onset type. Pediatr Neurol. 2006;35: 154–7.PubMedCrossRefGoogle Scholar
  652. 652.
    Moschner C, Perlman S, Baloh RW. Comparison of oculomotor findings in the progressive ataxia syndromes. Brain. 1994;117:15.PubMedCrossRefGoogle Scholar
  653. 653.
    Moser CL, Martín-Baranera M, Vega F, et al. Survey of blindness and visual impairment in Bioko, Equatorial Guinea. Br J Ophthalmol. 2002;86:257–60.PubMedPubMedCentralCrossRefGoogle Scholar
  654. 654.
    Moser HW, Mahmood A, Raymond GV. X-linked adrenoleukodystrophy. Nat Clin Pract Neurol. 2007;3:140–50.PubMedCrossRefGoogle Scholar
  655. 655.
    Mota A, Fonseca S, Ferreira CS, et al. Retinal nerve fiber layer thickness analysis with optical coherence tomography in Wolfram syndrome. Int J Opthalmic Pathol. 2013;2:1–4.Google Scholar
  656. 656.
    Moura AL, Nagy BV, La Morgia C, et al. The pupil light reflex in Leber’s hereditary optic neuropathy: evidence for preservation of melanopsin-expressing retinal ganglion cells. Invest Ophthalmol Vis Sci. 2013;54:4471–7.PubMedPubMedCentralCrossRefGoogle Scholar
  657. 657.
    Mudgil AV, Repka MX. Childhood optic atrophy. Clin Experiment Ophthalmol. 2000;28:34–7.PubMedCrossRefGoogle Scholar
  658. 658.
    Mukai K, Seljeskog EL, Dehner LP. Pituitary adenomas in patients under 20 years old. A clinicopathological study of 12 cases. J Neuro-Oncol. 1986;4:79–89.CrossRefGoogle Scholar
  659. 659.
    Mullaney PB, Jacquemin C, Al-Rashed W, et al. Growth retardation, alopecia, pseudoanodontia, and optic atrophy (GAPO syndrome) with congenital glaucoma. Arch Ophthalmol. 1997;115:940–1.PubMedCrossRefGoogle Scholar
  660. 660.
    Muller U, Steinberger D, Kunze S. Molecular genetics of craniosynostotic syndromes. Graefes Arch Clin Exp Ophthlamol. 1997;235:545–50.CrossRefGoogle Scholar
  661. 661.
    Munnich A, Rustin P, Rotig D, et al. Clinical aspects of mitochondrial disorders. J Inherit Metab Dis. 1992;15:448–55.PubMedCrossRefGoogle Scholar
  662. 662.
    Nabi NU, Mezer E, Blaser SI, et al. Ocular findings in lissencephaly. J AAPOS. 2003;7:178–84.PubMedCrossRefGoogle Scholar
  663. 663.
    Nakamura M, Ito S, Piao C-H. Retinal and optic disc atrophy associated with a CACNA1F mutation in a Japanese family. Arch Ophthalmol. 2003;121:1028–33.PubMedCrossRefGoogle Scholar
  664. 664.
    Nakamura M, Lin J, Ueno S, et al. Novel mutations in the OPA1 gene and associated clinical features in Japanese patients with optic atrophy. Ophthalmology. 2006;113:482–8.el.Google Scholar
  665. 665.
    Nakamura M, Tanigawa M, Yamamoto M. A case of Leber’s hereditary optic neuropathy with a mitochondrial DNA mutation at nucleotide position 3460. Jpn J Ophthalmol. 1994;38:267–71.Google Scholar
  666. 666.
    Nance MA, Berry SA. Cockayne syndrome: review of 140 cases. Am J Med Genet. 1992;42:68–84.PubMedCrossRefGoogle Scholar
  667. 667.
    Neas K, Bennetts B, Carpenter K, et al. OPA3 mutation screening in patients with unexplained 3-methylglutaconic aciduria. J Inherit Metab Dis. 2005;28:525–32.PubMedCrossRefGoogle Scholar
  668. 668.
    Neetens A, Leroy J, Smets RM. Menkes’ kinky hair disease. Bull Soc Belge Ophtal. 1982;203:75–83.PubMedGoogle Scholar
  669. 669.
    Neetens A, Martin JJ. The hereditary optic atrophies. Neuroophthalmology. 1986;6:277.CrossRefGoogle Scholar
  670. 670.
    Neetens A, Rubbens MC. Dominant juvenile optic atrophy. Ophthalmic Paediatr Genet. 1985;5:79–83.PubMedCrossRefGoogle Scholar
  671. 671.
    Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet al, Sly WS, Valle D, editors. The metabolic basis of inherited disease, vol. II. 6th ed. New York: McGraw-Hill; 1989. p. 1565–87.Google Scholar
  672. 672.
    Newman NJ. Hereditary optic neuropathies. In: Miller NR, Newman NJ, Bioussse V, Kerrison JB, editors. Walsh & Hoyt’s clinical neuro-ophthalmology, vol. 1. 6th ed. Baltimore: Lippincott Williams & Wilkins; 2005. p. 465–501.Google Scholar
  673. 673.
    Newman NJ. Hereditary optic neuropathies: from the mitochondria to the optic nerve. Am J Ophthalmol. 2005;140:517–23.PubMedGoogle Scholar
  674. 674.
    Newman NJ. Leber hereditary optic neuropathy: some new observations. J Neuroophthalmol. 2011;31:3–5.PubMedCrossRefGoogle Scholar
  675. 675.
    Newman NJ. Leber’s hereditary optic neuropathy. Ophthalmol Clin North Am. 1991;4:431–47.Google Scholar
  676. 676.
    Newman NJ. Leber’s hereditary optic neuropathy. New genetic considerations. Arch Neurol. 1993;50:540–8.PubMedCrossRefGoogle Scholar
  677. 677.
    Newman NJ. Optic disc pallor: a false localizing sign. Surv Ophthalmol. 1993;37:237–82.CrossRefGoogle Scholar
  678. 678.
    Newman NJ. Treatment of hereditary optic neuropathies. Nat Rev Neurol. 2012;8:545–56.PubMedCrossRefGoogle Scholar
  679. 679.
    Newman NJ, Biousse V. Hereditary optic neuropathies. Eye. 2004;18:1144–60.PubMedCrossRefGoogle Scholar
  680. 680.
    Newman NJ, Lott MT, Wallace DC. The clinical characteristics of pedigrees of Leber’s hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol. 1991;111(6):750–62.PubMedCrossRefGoogle Scholar
  681. 681.
    Newman SA. Ophthalmic features of craniosynostosis. Neurosurg Clin North Am. 1991;2:587–610.Google Scholar
  682. 682.
    Newman SA, Miller NR. Optic tract syndrome. Neuro-ophthalmologic considerations. Arch Ophthalmol. 1983;101: 1241–50.PubMedCrossRefGoogle Scholar
  683. 683.
    Newman-Toker DE, Horton JC, Lessell S. Recurrent visual loss in Leber hereditary optic neuropathy. Arch Ophthalmol. 2003;121:288–91.PubMedCrossRefGoogle Scholar
  684. 684.
    Nicolaides P, Appleton RE, Fryer A. Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS): a new syndrome. J Med Genet. 1996;33:419–21.PubMedPubMedCentralCrossRefGoogle Scholar
  685. 685.
    Nicolaides P, Leonard J, Aurtees R. Neurologic outcome of methylmalonic acidemia. Arch Dis Child. 1998;78:508–12.PubMedPubMedCentralCrossRefGoogle Scholar
  686. 686.
    Nikoskelainen E, Hoyt WF, Nummelin K. Ophthalmoscopic findings in Leber’s hereditary optic neuropathy. II. The fundus findings in the affected family members. Arch Ophthalmol. 1983;101:1059–68.PubMedCrossRefGoogle Scholar
  687. 687.
    Nikoskelainen EL, Huoponen K, Juvonen V, et al. Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology. 1996;103:504–14.PubMedCrossRefGoogle Scholar
  688. 688.
    Nikoskelainen EL, Marttila RJ, Huoponen K, et al. Leber’s “plus”: neurological abnormalities in patients with Leber’s hereditary optic neuropathy. J Neurol Neurosurg Psychiatry. 1995;59:160–4.PubMedPubMedCentralCrossRefGoogle Scholar
  689. 689.
    Nikoskelainen EK, Savontaus ML, Huoponen J, et al. Preexcitation syndrome in Leber’s hereditary optic neuropathy. Lancet. 1994;344:857–8.PubMedCrossRefGoogle Scholar
  690. 690.
    Nikoskelainen E, Savontaus ML, Wanne O, et al. Leber’s hereditary optic neuroretinopathy, a maternally inherited disease. A genealogic study in four pedigrees. Arch Ophthalmol. 1987;105: 665–71.PubMedCrossRefGoogle Scholar
  691. 691.
    Nikoskelainen E, Wanne O, Dahl M. Pre-excitation syndrome and Leber’s hereditary optic neuroretinopathy. Lancet. 1985;1:696.PubMedCrossRefGoogle Scholar
  692. 692.
    Nishiguchi KM, Avila-Fernandez A, van Huet RAC, et al. Exome sequencing extends the phenotypic spectrum for ABHD12 mutations. Ophthalmology. 2014;121:1620–7.PubMedCrossRefGoogle Scholar
  693. 693.
    Nishiuchi T, Imachi H, Murao K, et al. Suprasellar germinoma masquerading as lymphocytic hypophysitis associated with central diabetes insipidus, delayed sexual development, and subsequent hypopituitarism. Am J Med Sci. 2010;339:195–9.PubMedCrossRefGoogle Scholar
  694. 694.
    Nmorsi OP, Oladokun IA, Egwunyenga OA, et al. Eye lesions and onchocerciasis in a rural farm settlement in Delta state, Nigeria. Southeast Asian J Trop Med Public Health. 2002;33:28–32.PubMedGoogle Scholar
  695. 695.
    Nmorsi OP, Ukwandu NC, Alabi-Eric OJ, et al. CD4(+), CD8(+), immunoglobulin status and ocular lesions among some onchocerciasis-infected rural Nigerians. Parasitol Res. 2007;100: 1261–6.PubMedCrossRefGoogle Scholar
  696. 696.
    North KN, Korson MS, Gopol YR, et al. Neonatal-onset propionic acidemia: neurologic and developmental profiles, and implications for management. J Pediatr. 1995;126:916–22.Google Scholar
  697. 697.
    Novotny EJ, Singh G, Wallace DC, et al. Leber’s disease and dystonia. A mitochondrial disease. Neurology. 1986;36:1053–60.PubMedCrossRefGoogle Scholar
  698. 698.
    Numabe H. Optic atrophy, Behr syndrome. Ryoikibetsu Shokogun Shirizu. 2001;(34 Pt 2):382–3.Google Scholar
  699. 699.
    O’Hara CM, Izadi K, Albright AL, et al. Case report of optic atrophy in pansynostosis: an unusual presentation of scalp edema from hair braiding. Pediatr Neurosurg. 2006;42:100–4.PubMedCrossRefGoogle Scholar
  700. 700.
    Ohata T, Koizumi A, Kayo T, et al. Evidence of an increased risk of hearing loss in heterozygous carriers in a Wolfram syndrome family. Hum Genet. 1998;103:470–4.PubMedCrossRefGoogle Scholar
  701. 701.
    Ohba N, Imamura PM, Tanino T. Colour vision in a pedigree with autosomal dominant optic atrophy. Mod Probl Ophthalmol. 1976;17:315–9.PubMedGoogle Scholar
  702. 702.
    Ohlenbusch A, Wilichowski E, Hanefeld F, et al. Characterization of the mitochondrial genome in childhood multiple sclerosis. III. Multiple sclerosis without optic neuritis and the non-LHON-associated genes. Neuropediatrics. 1998;29:313–9.PubMedCrossRefGoogle Scholar
  703. 703.
    Ohtsuka Y, Amano R, Oka E, et al. Myoclonus epilepsy with ragged-red fibers: a clinical and electrophysiologic follow-up study on two sibling cases. J Child Neurol. 1993;8:366–72.PubMedCrossRefGoogle Scholar
  704. 704.
    Okamoto K, Tokiguchi S, Furusawa T, et al. MR features of diseases involving bilateral middle cerebellar peduncles. Am J Neuroradiol. 2003;24:1946–54.PubMedGoogle Scholar
  705. 705.
    O’Keefe M, Kafil-Hussain N, Flitcroft I, et al. Ocular significance of intraventricular haemorrhage in premature infants. Br J Ophthalmol. 2001;85:357–9.PubMedPubMedCentralCrossRefGoogle Scholar
  706. 706.
    Okuno T, Prensky AL, Gado M. The Moyamoya syndrome associated with irradiation of optic glioma in children: report of two cases and review of the literature. Pediatr Neurol. 1985;1:311–6.PubMedCrossRefGoogle Scholar
  707. 707.
    Olichon A, Baricault L, Gas N, et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome ce release and apoptosis. J Biol Chem. 2003;278:7743–6.PubMedCrossRefGoogle Scholar
  708. 708.
    Oluleye TS, Ajaiyeoba AI, Akinwale MO, et al. Causes of blindness in Southwestern Nigeria: a general hospital clinic study. Eur J Ophthalmol. 2006;16:604–7.PubMedGoogle Scholar
  709. 709.
    Opal P, Zoghbi HY. The hereditary ataxias. In: Rimoin DL, Connor JM, Pyeritz RE, editors. Emery and Rimoin’s principles and practice of medical genetics, vol. 3. 5th ed. Philadelphia: Elsevier; 2007. p. 2755–70.Google Scholar
  710. 710.
    Orbak Z, Orbak R, Ozkan B, et al. GAPO syndrome: first patients with partially empty sella. J Pediatr Endocrinol Metab. 2002;15:865–8.PubMedCrossRefGoogle Scholar
  711. 711.
    Orlin A, Sondhi D, Witmer MT, et al. Spectrum of ocular manifestations in CLN-2 associated Batten (Jansky-Bielschowsky) disease correlate with advancing and deteriorating neurological function. PLOS. 2013;8:e73128.CrossRefGoogle Scholar
  712. 712.
    Ormerod IE, Harding AE, Miller DH, et al. Magnetic resonance imaging in degenerative ataxic disorders. J Neurol Neurosurg Psychiat. 1994;57:51–7.PubMedPubMedCentralCrossRefGoogle Scholar
  713. 713.
    Orozco Diaz G, Nodarse Fleites A, Cordoves Sagaz R, et al. Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holguin, Cuba. Neurology. 1990;40:1369–75.PubMedCrossRefGoogle Scholar
  714. 714.
    Ortiz RG, Newman NJ, Manoukian S, et al. Optic disk cupping and electrocardiographic abnormalities in an American pedigree with Leber’s hereditary optic neuropathy. Am J Ophthalmol. 1992;113:561–6.PubMedCrossRefGoogle Scholar
  715. 715.
    Osaguona VB, Share JA, Awaji SA, et al. Optic chiasm involvement on MRI with ethambutol-induced bitemporal hemianopia. J Neuroophthalmol. 2014;34:155–8.PubMedCrossRefGoogle Scholar
  716. 716.
    Ouvrier RA. Pallor of the optic disc in children. Aust NZ J Ophthalmol. 1990;18:375–9.CrossRefGoogle Scholar
  717. 717.
    Ouvrier R, Grew S. Mechanisms of disease and clinical features of mutations of the gene for mitofusin 2: an important cause of hereditary peripheral neuropathy with striking clinical variability in children and adults. Dev Med Child Neurol. 2010;52:328–30.PubMedCrossRefGoogle Scholar
  718. 718.
    Ozden S, Düzcan F, Wollnik B, et al. Progressive autosomal dominant optic atrophy and sensorineural hearing loss in a Turkish family. Ophthalmic Genet. 2002;23:29–36.PubMedCrossRefGoogle Scholar
  719. 719.
    Ozkan H, Unsal E, Kose G. Oculocerebral hypopigmentation syndrome (Cross syndrome). Turk J Pediatr. 1991;33(4):247–52.PubMedGoogle Scholar
  720. 720.
    Pakdemirli E, Karabulut N, Bir LS, et al. Cranial magnetic resonance imaging of Wolfram (DIDMOAD) syndrome. Australas Radiol. 2005;49:189–91.PubMedCrossRefGoogle Scholar
  721. 721.
    Palan A, Stehouwer A, Went LN. Studies on Leber’s optic neuropathy III. Doc Ophthalmol. 1989;71:77–87.PubMedCrossRefGoogle Scholar
  722. 722.
    Papanagnu E, Brodsky MC. Is there a role for optokinetic nystagmus testing in contemporary orthoptic practice? Am Orthop J. 2014;64:1–10.CrossRefGoogle Scholar
  723. 723.
    Papay FA, Morales Jr L, Flaherty P, et al. Optic nerve decompression in cranial base fibrous dysplasia. J Craniofac Surg. 1995;6:5–10.PubMedCrossRefGoogle Scholar
  724. 724.
    Park H-YL, Park YG, Cho A-H, Park CK. Transneuronal retrograde degeneration of the retinal ganglion cells in patients with cerebral infarction. Ophthalmology. 2013;120:1292–9.PubMedCrossRefGoogle Scholar
  725. 725.
    Parness-Yossifon R, Listernick R, Charrow J, et al. Strabismus in patients with neurofibromatosis-associated type-1 optic pathway glioma. J AAPOS. 2015;19:422–5.Google Scholar
  726. 726.
    Parravano JG, Toledo A, Kucharczyk W. Dimensions of the optic nerves, chiasm, and tracts: MR quantitative comparison between patients with optic atrophy and normals. J Comput Assist Tomogr. 1993;17:688–90.PubMedCrossRefGoogle Scholar
  727. 727.
    Parsa CF. Why visual function does not correlate with optic glioma size or growth. JAMA Ophthalmol. 2013;131:121–4.PubMedGoogle Scholar
  728. 728.
    Parsa CS, Hoyt CS, Lesser RL, et al. Spontaneous regression of optic gliomas-thirteen cases documented by serial neuroimaging. Arch Ophthalmol. 2001;119:516–29.PubMedCrossRefGoogle Scholar
  729. 729.
    Pasik T, Pasik P. Optokinetic Nystagmus: an unlearned response altered by section of chiasma and corpus callosum in monkeys. Nature. 1964;203:609–11.PubMedCrossRefGoogle Scholar
  730. 730.
    Patil CG, Lad EM, Lad SP, et al. Visual loss after spine surgery: a population-based study. Spine (phila PA 1976). 2008;33(13): 1491–6.CrossRefGoogle Scholar
  731. 731.
    Patton N, Beatty S, Lloyd IC, et al. Optic atrophy in association with cobalamin C (cblC) disease. Ophthalmic Genet. 2000;21:151–4.PubMedCrossRefGoogle Scholar
  732. 732.
    Pauli RM. Sensorineural deafness and peripheral polyneuropathy. Clin Genet. 1984;26:383–4.PubMedCrossRefGoogle Scholar
  733. 733.
    Paulus W, Straube A, Bauer W, et al. Central nervous system involvement in Leber’s optic neuropathy. J Neurol. 1993;240: 251–3.PubMedCrossRefGoogle Scholar
  734. 734.
    Payne M, Yang Z, Katz BJ. Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoloplegia: a syndrome caused by a missense mutation in OPA1. Am J Ophthalmol. 2004;138:749–55.PubMedCrossRefGoogle Scholar
  735. 735.
    Pearce WG. Variable severity in autosomal dominant optic atrophy. Ophthalmic Paediatr Genet. 1985;5(1–2):99–102.PubMedCrossRefGoogle Scholar
  736. 736.
    Pena SD, Shokeir MH. The cerebro-oculo-facio-skeletal (COFS) syndrome. Clin Genet. 1974;5:285–93.PubMedCrossRefGoogle Scholar
  737. 737.
    Perrault I, Hanein S, Zanlonghi X, et al. Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy. Nat Genet. 2012;44:975–7.PubMedCrossRefGoogle Scholar
  738. 738.
    Peterson JR, Rosenberg T, Ibssen KK. Optic atrophy with particular attention to perinatal damage. Ugeskr Laeger. 1990;152: 3865–7.Google Scholar
  739. 739.
    Pezzi PP, De Negri AM, Sadun F, et al. Childhood Leber’s hereditary optic neuropathy (ND1/3460) with visual recovery. Pediatr Neurol. 1998;19:308–12.PubMedCrossRefGoogle Scholar
  740. 740.
    Pfeffer G, Burke A, Yu-Wai-Man P, et al. Clinical features of MS associated with Leber hereditary optic neuropathy. Neurology. 2013;81:2073–81.PubMedPubMedCentralCrossRefGoogle Scholar
  741. 741.
    Phasukkijwatana N, Chuenkongkaew WL, Suphavilai R, et al. The unique characteristics of Thai Leber hereditary optic neuropathy: analysis of 30 G11778A pedigrees. J Hum Genet. 2006;51:298–304.PubMedCrossRefGoogle Scholar
  742. 742.
    Phillips CI, Mackintosh GI, Howe JW, et al. Autosomal recessive “optic atrophy” with late onset and evidence of ganglion cell dysfunction: a sibship of two females. Ophthalmologica. 1993;206: 89–93.PubMedCrossRefGoogle Scholar
  743. 743.
    Phillips PH, Newman NJ. Mitochondrial diseases in pediatric ophthalmology. J AAPOS. 1997;1:115–22.PubMedCrossRefGoogle Scholar
  744. 744.
    Pilley SF, Thompson HS. Familial syndrome of diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) in children. Br J Ophthalmol. 1976;60:294–8.PubMedPubMedCentralCrossRefGoogle Scholar
  745. 745.
    Pinar-Sueiro S, Martinez-Fernandez R, et al. Optic neuropathy in methylmalonic aciduria: the role of neuroprotection. J Inherit Metab Dis. 2010;33:S199–203.PubMedCrossRefGoogle Scholar
  746. 746.
    Pineles SL, Avery RA, Liu GT. Vitamin B12 optic neuropathy in autism. Pediatrics. 2010;126:967–70.CrossRefGoogle Scholar
  747. 747.
    Pitz S, Ogun O, Bajbouj M, et al. Ocular changes in patients with mucopolysaccharidosis I receiving enzyme replacement therapy: a 4-year experience. Arch Ophthalmol. 2007;125:1353–6.PubMedCrossRefGoogle Scholar
  748. 748.
    Pollack IF, Losken HW, Biglan AW. Incidence of increased intracranial pressure after early surgical treatment of syndromic craniosynostosis. Pediatr Neurosurg. 1996;24:202–9.PubMedCrossRefGoogle Scholar
  749. 749.
    Pollock SC, Miller NR. The retinal nerve fiber layer. Int Ophthalmol Clin. 1986;26:201–21.PubMedCrossRefGoogle Scholar
  750. 750.
    Polymeropoulos MH, Swift RG, Swift M. Linkage of the gene for Wolfram syndrome to markers on the short arm of chromosome 4. Nat Genet. 1994;8:95.PubMedCrossRefGoogle Scholar
  751. 751.
    Pomeranz HD, Lessell S. A hereditary chiasmal optic neuropathy. Arch Ophthalmol. 1999;117:128–31.PubMedGoogle Scholar
  752. 752.
    Ponjavic V, Andréasson S. Multifocal ERG and full-field ERG, in patients on long-term vigabatrin medication. Doc Ophthalmol. 2001;102:63–72.PubMedCrossRefGoogle Scholar
  753. 753.
    Posnick JC, Wells MD, Drake JM, et al. Childhood fibrous dysplasia presenting as blindness: a skull base approach for resection and immediate reconstruction. Pediatr Neurosurg. 1993;19: 260–6.PubMedCrossRefGoogle Scholar
  754. 754.
    Poussaint TY, Barnes PD, Anthony DC. Hemorrhagic pituitary adenomas of adolescence. Am J Neuroradiol. 1996;17:1907–12.PubMedGoogle Scholar
  755. 755.
    Pradhan M, Sharp D, Best S, et al. Drug-induced optic neuropathy. TB or not TB. Surv Ophthalmol. 2010;55:378–85.PubMedCrossRefGoogle Scholar
  756. 756.
    Pretegiani E, Alessandra R, Gallus GN, et al. Spastic paraplegia in ‘dominant optic atrophy plus’ phenotype due to OPA1 mutation. Brain. 2011;134:1–3.CrossRefGoogle Scholar
  757. 757.
    Prietsch V, Peters V, Hackler R, et al. A new case of CDG-x with stereotyped dystonic hand movements and optic atrophy. J Inherit Metab Dis. 2002;25:126–30.PubMedCrossRefGoogle Scholar
  758. 758.
    Proud VK, Levine C, Carpenter NJ. New X-linked syndrome with seizures, acquired micrencephaly, and agenesis of the corpus callosum. Am J Med Genet. 1992;43(1–2):458–66.PubMedCrossRefGoogle Scholar
  759. 759.
    Pruzon J, Frohman L, Hood D, et al. Electroretinographic abnormalities in a case of Rosenberg-Chutorian syndrome. Presented as a poster at the North American Neuro-ophthalmology Society, Feb. 12–17, 2005, Copper Mountain, Colo.Google Scholar
  760. 760.
    Ptacek LJ. Autosomal dominant spinocerebellar atrophy with retinal degeneration. Clin Neurosci. 1995;3:28–32.PubMedGoogle Scholar
  761. 761.
    Puliafito CA, Wray SH, Murray JE, Boger WP. Am J Ophthalmol. 1981;92:696–701.PubMedCrossRefGoogle Scholar
  762. 762.
    Puomila A, Hämäläinen P, Kivioja S, et al. Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland. Eur J Hum Genet. 2007;15:1079–89.PubMedCrossRefGoogle Scholar
  763. 763.
    Puomila A, Huoponen K, Mäntjärvi M, et al. Dominant optic atrophy: correlation between clinical and molecular genetic studies. Acta Ophthalmol Scand. 2005;83:337–46.PubMedCrossRefGoogle Scholar
  764. 764.
    Pusey E, Kortman KE, Flannigan BD, et al. MR of craniopharyngioma: tumor delineation and characterization. AJR Am J Roentgenol. 1987;149:383–8.PubMedCrossRefGoogle Scholar
  765. 765.
    Rahman AM, Madge SN, Billing K, et al. Craniofacial fibrous dysplasia: clinical characteristic and long-term outcomes. Eye. 2009;23:2175–81.PubMedCrossRefGoogle Scholar
  766. 766.
    Rødahl E, Knappskog PM, Majeweski H, et al. Variants of anterior segment dysgenesis and cerebral involvement in a large family with a novel COL4A1 mutation. Am J Ophthalmol. 2013;155:946–53.PubMedCrossRefGoogle Scholar
  767. 767.
    Qi X, Hauswirth WW, Lewin AS, et al. Use of mitochondrial antioxidant defenses for rescue of cells with a Leber hereditary optic neuropathy-causing mutation. Arch Ophthalmol. 2007;125: 268–72.PubMedCrossRefGoogle Scholar
  768. 768.
    Qu J, Li R, Zhou X, et al. Cosegregation of the ND4 G11696A mutation with the LHON-associated ND4 G11778A mutation in a four-generation Chinese family. Mitochondrion. 2007;7:140–6.PubMedCrossRefGoogle Scholar
  769. 769.
    Qu J, Li R, Zhou X, et al. The novel A4435G mutation in the mitochondrial tRNAMet may modulate the phenotypic expression of the LHON-associated ND4 G11778A mutation. Invest Ophthalmol Vis Sci. 2006;47:475–83.PubMedCrossRefGoogle Scholar
  770. 770.
    Quigley HA, Anderson DR. The histologic basis of optic disk pallor in experimental optic atrophy. Am J Ophthalmol. 1977;83:709–17.PubMedCrossRefGoogle Scholar
  771. 771.
    Quigley HA, Davis EB, Anderson DR. Descending optic nerve degeneration in primates. Invest Ophthalmol Vis Sci. 1977;16: 841–9.PubMedGoogle Scholar
  772. 772.
    Quigley HA, Hohman RM, Addicks EM. Quantitative study of optic nerve head capillaries in experimental optic disc pallor. Am J Ophthalmol. 1982;93(6):689–99.PubMedCrossRefGoogle Scholar
  773. 773.
    Rahman S, Blok RB, Dahl H-H, et al. Leigh syndrome. Clinical features and biochemical and DNA abnormalities. Ann Neurol. 1996;39:343–51.PubMedCrossRefGoogle Scholar
  774. 774.
    Rahn EK, Yanoff M, Tucker S. Neuro-ocular considerations in the Pelizaeus-Merzbacher syndrome: a clinicopathologic study. Am J Ophthalmol. 1968;66:1143–51.PubMedCrossRefGoogle Scholar
  775. 775.
    Rando TA, Horton JC, Layzer RB. Wolfram syndrome: evidence of a diffuse neurodegenerative disease by magnetic resonance imaging. Neurology. 1992;42:1220–4.PubMedCrossRefGoogle Scholar
  776. 776.
    Ranjan P, Kalita J, Misra UK. Serial study of clinical and CT changes in tuberculous meningitis. Neuroradiology. 2003;45: 277–82.PubMedGoogle Scholar
  777. 777.
    Rapid I, Traeger E. Cerebral degenerations of childhood. In: Rowland LP, editor. Merritt’s textbook of neurology. 9th ed. Baltimore: Williams & Wilkins; 1995. p. 547–71.Google Scholar
  778. 778.
    Rapin I, Traeger E. Differential diagnosis. In: Rowland LP, editor. Merritt’s textbook of neurology. 9th ed. Baltimore: Williams & Wilkins; 1995. p. 597–603.Google Scholar
  779. 779.
    Rendtorff ND, Lodohl M, Boulahbel H, et al. Identification of p.A684V missense mutation in the WFS1 gene of autosomal dominant optic atrophy and hearing impairment. Am J Med Genet A. 2011;155:1298–313.PubMedCentralCrossRefGoogle Scholar
  780. 780.
    Repka MX. Ophthalmological problems of the premature infant. Ment Retard Dev Disabil Res Rev. 2002;8:249–57.PubMedCrossRefGoogle Scholar
  781. 781.
    Repka MX, Miller NR. Optic atrophy in children. Am J Ophthalmol. 1988;106:191–3.PubMedCrossRefGoogle Scholar
  782. 782.
    Repka MX, Miller NR, Miller M. Visual outcome after surgical removal of craniopharyngiomas. Ophthalmology. 1989;96:195–9.PubMedCrossRefGoogle Scholar
  783. 783.
    Reynier P, Amati-Bonneau P, Verny C, et al. OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract. J Med Genet. 2004;41:e110.PubMedPubMedCentralCrossRefGoogle Scholar
  784. 784.
    Richmond IL, Wilson CB. Pituitary adenomas in childhood and adolescence. J Neurosurg. 1978;49:163–8.PubMedCrossRefGoogle Scholar
  785. 785.
    Riggs JE, Ellis BD, Hogg JP, et al. Acute periaqueductal syndrome associated with the G11778A mitochondrial DNA mutation. Neurology. 2001;56:570–1.PubMedCrossRefGoogle Scholar
  786. 786.
    Rigoli L, Di Bella C. Wolfram syndrome 1 and Wolfram syndrome 2. Curr Opin Pediatr. 2012;24:512–7.PubMedGoogle Scholar
  787. 787.
    Riikonen R. The PEHO syndrome. Brain Dev. 2001;23:765–9.PubMedCrossRefGoogle Scholar
  788. 788.
    Riikonen R, Somer M, Turpeinen U. Low insulin-like growth factor (IGF-1) in the cerebrospinal fluid of children with progressive encephalopathy, hypsarrhythmia, and optic atrophy (PEHO) syndrome and cerebellar degeneration. Epilepsia. 1999;40:1642–8.PubMedCrossRefGoogle Scholar
  789. 789.
    Riordan-Eva P, Sanders MD, Govan GG, et al. The clinical features of Leber’s hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain. 1995;118:319–37.PubMedCrossRefGoogle Scholar
  790. 790.
    Rizvi R, Anjum Q. Hydrocephalus in children. J Pak Med Assoc. 2005;55:502–7.PubMedGoogle Scholar
  791. 791.
    Rizzo JF, Lessell S, Liebman S. Optic atrophy in familial dysautonomia. Am J Ophthalmol. 1986;102:463–7.PubMedCrossRefGoogle Scholar
  792. 792.
    Robb RM, Dowton SB, Fulton AB, et al. Retinal degeneration in vitamin B12 disorder associated with methylmalonic aciduria and sulfur amino acid abnormalities. Am J Ophthalmol. 1984;97: 691–6.PubMedCrossRefGoogle Scholar
  793. 793.
    Roberts I, Yates D, Sandercock P, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomized placebocontrolled trial. Lancet. 2004;364:1321–8.PubMedCrossRefGoogle Scholar
  794. 794.
    Roggeveen HC, de Winter AP, Went LN. Studies in dominant optic atrophy. Ophthalmic Paediatr Genet. 1985;5:103–9.PubMedCrossRefGoogle Scholar
  795. 795.
    Ron E, Modam B, Boice JD, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med. 1988;319:1033.PubMedCrossRefGoogle Scholar
  796. 796.
    Rose AL, Farmer PM, Mitra N, et al. Clinical, pathologic, and neurochemical studies of an unusual case of neuronal storage disease with lamellar cytoplasmic inclusions: a new genetic disorder? J Child Neurol. 1999;14:123–9.PubMedCrossRefGoogle Scholar
  797. 797.
    Rosenberg RN, Chutorian A. Familial opticoacoustic nerve degeneration and polyneuropathy. Neurology. 1967;17:827–32.PubMedCrossRefGoogle Scholar
  798. 798.
    Rosenberg RN, Grossman A. Hereditary ataxia. Neurol Clin. 1989;7:25–36.PubMedGoogle Scholar
  799. 799.
    Rosenblatt DS, Aspler AL, Shevell MI. Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC). J Inherit Met Dis. 1997;20:528–38.CrossRefGoogle Scholar
  800. 800.
    Rosenfeld A, Arrington D, Miller J, et al. A review of childhood and adolescent craniopharyngiomas with particular attention to hypothalamic obesity. Pediatr Neurol. 2014;50:4–10.PubMedCrossRefGoogle Scholar
  801. 801.
    Rotig A, Cormier V, Chatelain P, et al. Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy, and deafness (Wolfram syndrome, MIM 222300). J Clin Invest. 1993;91(3):1095–8.PubMedPubMedCentralCrossRefGoogle Scholar
  802. 802.
    Rouzier C, Bannwarth S, Chaussenot A, et al. The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy “plus” syndrome. Brain. 2012;135:23–34.PubMedCrossRefGoogle Scholar
  803. 803.
    Rouzier CA, Monnot S, Chabroi B, et al. Identification of novel mutations in WFS1 and genotype-phenotype correlation in Wolfram syndrome. Am J Med Genet. 2007;143A:1605–12.PubMedCrossRefGoogle Scholar
  804. 804.
    Ruberto G, Salati R, Milano G, et al. Changes in the optic disc excavation of children affected by cerebral visual impairment: a tomographic analysis. Invest Ophthalmol Vis Sci. 2006;47:484–8.PubMedCrossRefGoogle Scholar
  805. 805.
    Rudanko SL, Fellman V, Laatikainen L. Visual impairment in children born prematurely from 1972 to 1989. Ophthalmology. 2003;110:1639–45.PubMedCrossRefGoogle Scholar
  806. 806.
    Rudanko SL, Laatikainen L. Visual impairment in children born at full term from 1972 through 1989 in Finland. Ophthalmology. 2004;111:2307–12.PubMedCrossRefGoogle Scholar
  807. 807.
    Rudolph G, Dimitriadis K, Büchner B, et al. Effects of idebenone on color vision in patients with Leber hereditary optic neuropathy. J Neuroophthalmol. 2013;33:30–6.PubMedPubMedCentralCrossRefGoogle Scholar
  808. 808.
    Rüther K, Pung T, Kellner U, Schmitz B, Hartmann C, Seeliger M. Electrophysiologic evaluation of patients with peripheral visual field contraction associated with vigabatrin. Arch Ophthalmol. 1998;116:817–9.Google Scholar
  809. 809.
    Rutner D, Kapoor N, Ciuffreda KJ, et al. Occurrence of ocular disease in traumatic brain injury in a selected sample: a retrospective analysis. Brain Inj. 2006;20:1079–86.PubMedCrossRefGoogle Scholar
  810. 810.
    Rutzen AR, Ellish NJ, Schwab L, et al. Blindness and eye disease in Cambodia. Ophthalmic Epidemiol. 2007;14:360–6.PubMedCrossRefGoogle Scholar
  811. 811.
    Ryan SJ, Smith RE. Retinopathy associated with hereditary olivopontocerebellar degeneration. Am J Ophthalmol. 1971;71:838.PubMedCrossRefGoogle Scholar
  812. 812.
    Saas JO, Hofmann M, Skladal D, et al. Propionic acidemia revisited: a workshop report. Clin Pediatr. 2004;43:837–43.CrossRefGoogle Scholar
  813. 813.
    Saatci U, Soylemezoglu O, Ozen S, et al. Diabetes mellitus, diabetes insipidus, optic atrophy and deafness (DIDMOAD syndrome). Turk J Pediatr. 1990;32:211–5.PubMedGoogle Scholar
  814. 814.
    Sachdev MS, Kumar H, Jain AK, et al. Transsynaptic neuronal degeneration of optic nerves associated with bilateral occipital lesions. Ind J Ophthalmol. 1990;38:151–2.Google Scholar
  815. 815.
    Sadun AA. Acquired mitochondrial impairment as a cause of optic nerve disease. Trans Am Ophthalmol Soc. 1998;96:881–923.PubMedPubMedCentralGoogle Scholar
  816. 816.
    Sadun AA. Are we there yet? Is neuro-ophthalmology at the cusp of a paradigm shift? Lessons from Leber hereditary optic neuropathy. J Neuroophthalmol. 2013;33:189–97.PubMedCrossRefGoogle Scholar
  817. 817.
    Sadun AA. Metabolic optic neuropathies. Semin Ophthalmol. 2002;17:29–32.PubMedCrossRefGoogle Scholar
  818. 818.
    Sadun AA, Carelli V, Salomao SR. Extensive investigation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol. 2003;136:231–8.PubMedCrossRefGoogle Scholar
  819. 819.
    Sadun AA, Chicani CF, Ross-Cisneros FN, et al. Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy. Arch Neurol. 2012;69:331–8.PubMedCrossRefGoogle Scholar
  820. 820.
    Sadun F, De Negri AM, Carelli V, et al. Ophthalmologic findings in a large pedigree of 11778/Haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol. 2004;137:271–7.PubMedCrossRefGoogle Scholar
  821. 821.
    Sadun AA, Kashima Y, Wurdeman AE, et al. Morphological findings in the visual system in a case of Leber’s hereditary optic neuropathy. Clin Neurosci. 1994;2:165–72.Google Scholar
  822. 822.
    Sadun AA, Martone JF, Muci-Mendoza R, et al. Epidemic optic neuropathy in Cuba. Eye findings. Arch Ophthalmol. 1994;112:691–9.PubMedCrossRefGoogle Scholar
  823. 823.
    Sadun AA, Salomao SR, Berezovsky A, et al. Subclinical carriers and conversions in Leber hereditary optic neuropathy: a prospective psychophysical study. Trans Am Ophthalmol Soc. 2006;104:51–61.PubMedPubMedCentralGoogle Scholar
  824. 824.
    Sadun AA, Wang MY. Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year. J Neuroophthalmol. 2008;28:265–8.PubMedCrossRefGoogle Scholar
  825. 825.
    Saeed P, Rootman J, Nugent RA, et al. Optic nerve sheath meningiomas. Ophthalmology. 2003;110:2019–30.PubMedCrossRefGoogle Scholar
  826. 826.
    Safran AB, Lupolover Y, Berney J. Macular reflexes in optic atrophy. Am J Ophthalmol. 1984;98:494.PubMedCrossRefGoogle Scholar
  827. 827.
    Salbert BA, Astruc J, Wolf B. Ophthalmologic findings in biotinidase deficiency. Ophthalmologica. 1993;206(4):177–81.PubMedCrossRefGoogle Scholar
  828. 828.
    Salih MA, Tuvemo T. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD syndrome). A clinical study in two Sudanese families. Acta Paediatr Scand. 1991;80:567–72.PubMedCrossRefGoogle Scholar
  829. 829.
    Salonen R, Somer M, Haltia M, et al. Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO syndrome). Clin Genet. 1991;39:287–93.PubMedCrossRefGoogle Scholar
  830. 830.
    Sanchez RN, Smith AJ, Carelli V, et al. Ischemic optic neuropathy possibly triggered by exposure to tire fire. J Neuroophthalmol. 2005;26:268–72.CrossRefGoogle Scholar
  831. 831.
    Santorelli FM, Shanske S, Macaya A, et al. The mutation at nt8993 of mitochondrial DNA is a common cause of Leigh’s syndrome. Ann Neurol. 1993;34:827–34.PubMedCrossRefGoogle Scholar
  832. 832.
    Sapey E, Burdon MA, Nightingale S. Evidence of active demyelination in a man with Leber’s hereditary optic neuropathy mtDNA 14484 genotype. Neuro-Ophthalmology. 2001;26:119–26.CrossRefGoogle Scholar
  833. 833.
    Sarkar HR, Hossain MA, Mazumder U, et al. Clinical picture of craniopharyngioma in childhood. Mymensigh Med J. 2007; 16L:123–6.Google Scholar
  834. 834.
    Sathasivam S. Brown-Vialetto-Van Laere syndrome. Orphanet J Rare Dis. 2008;3:9.PubMedPubMedCentralCrossRefGoogle Scholar
  835. 835.
    Saugier-Veber P, Munnich A, Bonneau D, et al. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet. 1